rfhg_121556.1

Basic information about the TSS

---

TSS ID: rfhg_121556.1 Species: human Chr: chr9		Start: 137101097 End: 137101133 Strand: +
Source datasets	PRJDB5282
Protocol	C1CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: AL110221:491 GeneID: 11253 HGNC/MGI_ID: HGNC:6823 UniProt_ID: Q9UFZ8 Nearer transcript ids and distances:

Gene_name: mannosidase alpha class 1B member 1 Gene_symbol: MAN1B1 Gene_synonyms: ERMan1 ERManI MANA-ER MRT15 Gene_source: HGNC:6823

TATA-Box annotation

---

Distance to TSS:	13618
Nearest PromoterID:	NM_013379
Entrez ID:	29952
Nearest Unigene:	Hs.37916
Nearest Refseq:	NM_013379
Nearest Ensembl:	ENSG00000176978
Gene Name:	mannosidase alpha class 1B member 1
Gene Alias:	DPP2|DPPII|QPP
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	0.675676
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@MAN1B1 p2@MAN1B1 p3@MAN1B1 p4@MAN1B1
Sample		p1@MAN1B1	p2@MAN1B1	p3@MAN1B1	p4@MAN1B1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	12.66	1.17	0.97	0.19
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	13.96	1.01	0.81	0.20
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	14.47	0.39	0.58	0.19
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	12.06	0.00	0.21	1.04
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	12.82	0.67	0.67	0.67
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	11.24	0.58	1.16	0.58
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	10.46	1.31	0.65	0.22
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	9.20	0.73	1.21	0.24
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	10.90	0.64	0.85	0.43
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	8.69	0.58	0.58	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	16.17	1.62	2.43	0.81
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	12.20	1.63	1.63	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	58.67	20.47	2.90	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	49.47	18.04	1.80	1.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	41.72	15.37	3.07	1.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	51.05	19.62	1.26	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	45.65	16.38	2.62	1.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	51.88	25.73	2.95	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	53.85	19.19	3.73	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	46.79	18.50	3.31	0.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	47.31	19.51	3.88	1.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	55.58	15.54	3.45	1.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	46.14	15.51	3.10	1.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	43.44	15.53	2.91	2.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	45.92	20.90	2.58	1.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	44.31	18.04	2.22	0.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	43.41	17.58	1.65	1.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	50.45	18.15	3.54	1.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	45.23	17.44	3.07	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	43.43	15.20	2.35	0.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	38.73	13.19	2.09	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	42.98	12.90	3.13	1.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	48.33	20.26	2.11	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	47.50	29.36	3.79	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	39.45	15.33	2.06	1.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	40.05	13.41	1.34	0.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	41.28	13.28	3.07	2.04
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	42.31	13.50	3.22	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	40.52	12.15	1.08	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	35.05	15.12	0.72	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	36.47	12.70	1.88	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	37.77	18.15	2.49	1.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	37.12	14.55	2.11	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	39.69	15.91	2.45	1.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	31.92	13.05	3.41	1.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	38.85	10.47	2.79	1.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	31.43	12.24	1.68	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	36.36	14.60	2.68	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	35.19	12.69	1.68	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	34.98	13.55	3.64	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	31.36	8.81	1.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	33.36	10.01	1.78	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	41.98	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	40.10	8.52	2.13	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	35.13	9.61	0.99	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	17.62	10.91	3.36	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	21.13	8.27	4.13	0.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	26.90	6.48	1.62	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	33.72	7.71	1.28	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	22.95	8.80	3.14	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	37.37	4.94	2.12	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	32.53	7.29	1.68	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	13.53	9.55	0.80	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	14.27	7.14	1.36	0.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	19.17	5.20	1.62	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	29.11	6.03	1.06	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	16.16	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	15.79	7.90	7.90	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	43.39	7.31	1.95	0.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	54.55	8.93	2.98	1.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	35.18	8.91	2.35	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	34.44	8.61	2.98	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	47.33	5.88	3.09	1.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	52.89	8.56	2.75	1.53
Adipocyte - breast, donor1	11376-118A8	75.07	3.80	1.58	1.43
Adipocyte - breast, donor2	11327-117E4	53.58	3.21	1.28	0.80
Adipocyte - omental, donor1	11473-119C6	79.64	6.74	2.16	1.15
Adipocyte - omental, donor2	11474-119C7	82.22	5.23	2.24	0.75
Adipocyte - omental, donor3	11475-119C8	62.96	3.01	1.67	0.33
Adipocyte - perirenal, donor1	11476-119C9	61.89	3.19	1.91	1.28
Adipocyte - subcutaneous, donor1	11259-116F8	30.79	1.10	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	41.55	1.81	2.26	0.90
Adipocyte - subcutaneous, donor3	11408-118E4	43.79	1.22	0.17	0.17
Adipocyte differentiation, day04, donor1	13019-139D4	48.31	6.45	1.17	0.20
Adipocyte differentiation, day04, donor2	13022-139D7	36.81	4.63	0.77	0.51
Adipocyte differentiation, day04, donor3	13025-139E1	34.57	5.85	1.12	0.84
Adipocyte differentiation, day04, donor4	13028-139E4	41.15	4.11	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	33.06	4.18	0.80	0.24
Adipocyte differentiation, day08, donor2	13023-139D8	42.93	5.81	0.32	0.65
Adipocyte differentiation, day08, donor3	13026-139E2	33.59	4.27	2.13	1.07
Adipocyte differentiation, day08, donor4	13029-139E5	37.28	0.56	0.00	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	56.56	4.99	0.42	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	36.42	4.02	0.75	0.75
Adipocyte differentiation, day12, donor3	13027-139E3	43.52	2.95	0.00	0.65
Adipocyte differentiation, day12, donor4	13030-139E6	31.97	1.52	0.00	0.61
Alveolar Epithelial Cells, donor1	11510-119G7	34.48	5.97	1.55	0.88
Alveolar Epithelial Cells, donor2	11590-120G6	37.29	9.32	3.23	1.79
Alveolar Epithelial Cells, donor3	11671-122G6	43.13	8.39	3.59	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	54.33	14.39	1.98	0.36
Amniotic Epithelial Cells, donor2	11613-122A2	73.63	18.41	1.67	6.69
Amniotic Epithelial Cells, donor3	11694-123A2	56.91	10.68	2.05	1.44
Anulus Pulposus Cell, donor1	11248-116E6	54.58	6.29	0.69	0.34
Anulus Pulposus Cell, donor2	11463-119B5	56.08	5.88	1.47	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	52.12	8.09	1.80	2.70
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	50.79	9.55	2.60	1.30
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	42.80	6.42	2.14	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	44.24	6.28	1.20	1.79
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	61.97	11.38	2.53	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	46.20	6.60	1.32	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	45.81	9.75	2.27	1.95
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	52.43	6.80	1.94	1.46
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	51.07	8.31	1.19	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	43.31	8.66	1.88	0.75
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	47.17	10.16	0.00	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	38.87	7.52	1.25	5.02
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	49.26	5.93	1.48	1.98
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	35.48	9.55	1.36	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	44.18	7.09	1.81	1.51
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	60.01	9.11	3.21	2.14
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	46.67	7.37	1.51	1.51
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	60.67	8.82	3.47	1.34
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	45.85	8.78	0.98	0.98
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	44.78	6.80	1.66	1.33
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	52.83	12.01	1.20	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	56.64	10.62	0.00	3.54
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	51.12	6.35	1.72	1.03
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	33.56	16.78	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	66.50	10.19	2.43	0.97
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	45.53	8.73	4.17	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	46.03	7.27	1.21	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	46.17	9.12	3.42	1.14
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	56.65	9.19	2.35	1.28
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	57.55	5.68	1.81	1.55
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	56.30	7.04	2.35	1.41
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	49.52	3.86	0.64	0.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	42.09	9.27	2.14	2.14
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	42.70	7.60	3.51	2.92
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	47.87	6.92	1.20	0.60
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	54.65	8.32	3.56	1.19
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	41.19	8.65	1.53	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	47.12	6.11	2.04	0.76
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	44.48	3.81	3.18	2.54
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	51.78	6.04	2.59	2.16
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	52.50	5.93	3.39	1.27
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	49.30	9.28	1.45	2.03
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	45.35	9.45	1.89	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	49.67	6.10	1.86	1.02
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	39.38	4.63	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	48.59	8.45	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	45.24	6.00	2.36	0.64
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	50.54	8.42	1.80	3.01
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	45.93	5.10	4.37	2.19
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	49.19	7.36	3.68	1.61
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	43.36	12.75	2.55	2.55
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	49.07	6.36	1.53	1.27
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	54.50	9.50	1.86	1.86
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	48.65	11.02	1.22	0.92
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	54.97	4.78	1.91	2.87
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	51.67	6.87	2.66	1.77
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	35.09	4.58	0.00	3.05
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	42.10	7.75	1.11	3.88
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	42.63	8.47	1.32	1.59
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	43.25	8.00	2.54	0.36
Astrocyte - cerebellum, donor1	11500-119F6	82.66	4.54	0.25	0.49
Astrocyte - cerebellum, donor2	11580-120F5	72.23	5.31	1.03	0.51
Astrocyte - cerebellum, donor3	11661-122F5	74.67	4.82	0.63	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	46.71	6.62	0.00	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	40.28	3.07	0.16	0.32
Astrocyte - cerebral cortex, donor3	11392-118C6	35.95	2.54	0.89	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	9.75	9.29	0.92	0.57
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	11.28	7.77	0.50	0.38
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	10.36	7.06	0.80	0.46
Basophils, donor1	12241-129G9	15.69	8.37	0.52	0.26
Basophils, donor2	12242-129H1	24.53	11.55	0.00	0.36
Basophils, donor3	12243-129H2	12.94	9.85	1.03	0.15
Bronchial Epithelial Cell, donor1	11511-119G8	49.59	6.25	1.29	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	80.01	13.72	3.20	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	64.56	21.52	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	26.99	6.28	0.63	1.26
Bronchial Epithelial Cell, donor5	11457-119A8	42.21	5.61	1.04	0.83
Bronchial Epithelial Cell, donor6	11461-119B3	35.70	5.53	0.23	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	41.39	2.16	1.08	0.36
Burkitt's lymphoma cell line:DAUDI	10422-106C8	12.57	14.22	0.93	0.72
Burkitt's lymphoma cell line:RAJI	10476-106I8	18.63	13.51	0.70	0.93
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	24.30	6.40	0.96	0.96
CD133+ stem cells - cord blood derived, pool1	12223-129E9	10.34	10.34	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	12.96	8.45	0.56	0.00
CD14+ Monocytes, donor2	11305-117B9	12.81	7.80	1.11	0.56
CD14+ Monocytes, donor3	11381-118B4	10.54	9.00	1.10	0.66
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	33.40	16.13	2.83	0.85
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	22.37	15.54	1.14	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	22.03	15.12	0.99	0.99
CD14+ monocytes - mock treated, donor1	11863-125A9	6.50	10.12	0.87	0.29
CD14+ monocytes - mock treated, donor2	11873-125C1	4.53	6.64	1.21	0.60
CD14+ monocytes - mock treated, donor3	11883-125D2	8.53	4.26	0.47	0.95
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	5.69	5.36	1.00	0.50
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	4.97	7.18	0.00	0.28
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	3.97	4.96	0.25	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	2.55	5.29	0.59	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	3.38	4.27	0.89	0.18
CD14+ monocytes - treated with BCG, donor3	11880-125C8	6.09	5.44	0.44	0.22
CD14+ monocytes - treated with Candida, donor1	11868-125B5	4.92	6.32	0.70	0.23
CD14+ monocytes - treated with Candida, donor2	11878-125C6	4.75	6.86	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	8.87	4.44	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	5.06	5.80	0.59	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	4.39	3.39	0.80	0.40
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	3.75	5.00	0.00	0.42
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	4.35	7.55	1.37	0.23
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	2.26	6.11	0.68	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	3.49	5.24	0.44	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	3.50	7.53	0.54	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	5.06	7.68	0.17	0.35
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	6.31	6.31	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	3.86	4.78	0.00	0.73
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	1.76	2.11	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	1.75	3.51	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	3.84	4.53	0.52	0.17
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	4.46	7.06	0.37	0.37
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	7.54	6.25	0.43	0.22
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	5.73	4.91	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	2.78	4.64	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	1.86	3.48	0.00	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	13.08	10.24	0.22	0.65
CD14+CD16+ Monocytes, donor2	11801-124D1	15.01	10.63	0.69	0.23
CD14+CD16+ Monocytes, donor3	11912-125G4	9.53	8.23	0.87	0.22
CD14+CD16- Monocytes, donor1	11788-124B6	16.20	15.26	0.93	0.62
CD14+CD16- Monocytes, donor2	11799-124C8	17.99	14.50	1.22	0.70
CD14+CD16- Monocytes, donor3	11910-125G2	13.82	16.95	2.01	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	26.54	5.87	0.77	0.51
CD14-CD16+ Monocytes, donor2	11800-124C9	20.86	9.44	0.88	0.22
CD14-CD16+ Monocytes, donor3	11911-125G3	24.21	9.26	0.84	0.21
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	10.16	20.32	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	9.49	23.05	1.36	0.68
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	11.39	18.64	1.04	2.07
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	13.86	19.19	2.67	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	11.26	24.12	0.54	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	10.53	13.34	2.81	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	10.98	22.75	0.00	0.78
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	11.86	19.77	0.00	1.32
CD19+ B Cells, donor1	11544-120B5	8.22	13.97	0.82	0.82
CD19+ B Cells, donor2	11624-122B4	7.98	22.49	0.73	0.73
CD19+ B Cells, donor3	11705-123B4	4.54	12.62	2.02	0.50
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	19.39	1.21	0.00	0.40
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	11.19	1.20	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	16.06	10.04	1.00	0.00
CD34+ Progenitors, donor2	11625-122B5	14.05	7.30	0.56	1.12
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	22.55	11.65	0.75	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	29.09	11.05	1.35	0.00
CD4+ T Cells, donor1	11225-116C1	28.21	13.21	1.07	0.71
CD4+ T Cells, donor2	11306-117C1	32.46	16.53	0.00	1.22
CD4+ T Cells, donor3	11382-118B5	30.50	12.50	1.22	0.30
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	30.12	16.85	1.02	0.77
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	38.63	16.17	0.67	0.45
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	39.38	16.39	1.72	0.57
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	40.77	15.17	2.37	0.95
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	42.14	18.26	0.00	0.70
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	46.15	16.48	0.00	3.30
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	18.50	23.70	1.16	0.72
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	22.20	13.39	1.02	0.51
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	21.60	14.51	0.97	0.64
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	24.66	17.04	2.24	0.90
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	25.16	18.87	0.70	0.70
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	40.92	15.40	2.20	0.88
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	23.19	18.13	1.69	0.84
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	21.19	17.87	1.45	0.62
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	24.39	21.38	0.33	0.33
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	48.13	15.77	0.82	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	68.60	18.76	2.68	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	62.76	1.79	1.79	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	22.25	26.52	2.78	0.74
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	22.74	19.93	1.08	0.87
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	26.90	15.34	1.26	0.84
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	37.92	12.13	1.52	0.51
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	32.06	15.60	1.30	0.87
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	39.22	10.90	0.44	0.44
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	56.42	9.40	0.49	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	38.77	14.77	0.00	1.85
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	43.27	16.75	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	60.09	22.99	1.38	0.28
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	71.41	21.59	1.23	0.49
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	67.76	16.94	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	50.85	16.83	0.36	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	54.01	11.08	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	25.54	10.15	0.98	0.33
CD8+ T Cells, donor2	11307-117C2	31.91	9.01	0.00	0.38
CD8+ T Cells, donor3	11383-118B6	27.77	6.06	0.76	0.50
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	9.63	4.36	1.61	1.61
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	11.50	5.03	2.16	0.72
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	9.03	6.84	1.92	1.09
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	9.91	6.60	3.30	1.50
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	9.12	5.52	2.40	1.20
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	10.91	6.14	2.27	1.36
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	7.39	6.30	1.96	1.74
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	2.63	5.00	3.16	1.05
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	4.69	5.16	1.64	0.94
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	6.34	9.96	2.11	0.60
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	5.52	7.84	3.20	0.58
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	4.80	7.19	3.46	0.27
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	3.50	6.57	2.19	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	5.47	5.92	1.37	0.91
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	4.48	4.48	1.49	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	10.44	5.40	3.60	0.72
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	7.48	7.19	1.15	0.58
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	7.54	6.13	1.89	1.41
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	5.07	5.07	2.85	0.63
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	4.61	4.61	1.85	0.92
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	5.77	4.49	2.89	1.28
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	7.27	5.74	2.29	0.76
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	2.76	4.73	3.15	2.36
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	7.56	7.56	2.27	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	4.01	7.23	1.61	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	5.60	7.69	3.50	1.40
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	6.01	10.02	1.00	1.00
Cardiac Myocyte, donor1	11525-119I4	67.63	3.66	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	45.46	7.41	0.99	0.00
Cardiac Myocyte, donor3	11686-122I3	51.67	3.89	0.84	0.32
Chondrocyte - de diff, donor1	11261-116G1	56.51	5.89	2.08	0.35
Chondrocyte - de diff, donor2	11338-117F6	53.31	4.26	1.07	1.07
Chondrocyte - de diff, donor3	11410-118E6	46.65	4.32	1.48	0.46
Chondrocyte - re diff, donor2	11339-117F7	50.13	9.85	1.79	0.00
Chondrocyte - re diff, donor3	11411-118E7	65.11	7.68	2.02	0.81
Ciliary Epithelial Cells, donor1	11242-116D9	68.28	2.64	0.46	0.11
Ciliary Epithelial Cells, donor2	11323-117D9	54.51	5.13	1.07	0.43
Ciliary Epithelial Cells, donor3	11399-118D4	62.39	3.27	1.33	0.44
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	47.68	2.93	0.73	0.92
Corneal Epithelial Cells, donor1	11526-119I5	53.80	3.51	0.22	0.44
Corneal Epithelial Cells, donor2	11606-120I4	28.44	7.96	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	40.13	1.79	1.53	0.51
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	1.82	21.46	3.14	1.16
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	3.47	17.03	3.47	1.26
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	0.00	10.35	6.90	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	5.29	15.66	4.10	1.62
Dendritic Cells - plasmacytoid, donor1	11228-116C4	6.15	30.75	1.37	2.05
Dendritic Cells - plasmacytoid, donor2	11309-117C4	6.53	20.24	1.96	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	4.84	23.71	4.36	3.39
Endothelial Cells - Aortic, donor0	11207-116A1	22.68	11.67	2.50	0.50
Endothelial Cells - Aortic, donor1	11263-116G3	25.82	9.98	2.93	1.17
Endothelial Cells - Aortic, donor2	11340-117F8	56.56	16.40	3.96	0.85
Endothelial Cells - Aortic, donor3	11412-118E8	32.24	8.65	1.18	0.00
Endothelial Cells - Artery, donor1	11264-116G4	48.58	8.73	4.65	2.33
Endothelial Cells - Artery, donor2	11341-117F9	42.59	7.53	2.12	0.47
Endothelial Cells - Artery, donor3	11413-118E9	25.24	6.14	2.28	0.18
Endothelial Cells - Lymphatic, donor1	11236-116D3	32.36	13.96	2.44	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	40.47	10.04	3.35	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	41.16	12.40	2.82	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	39.52	14.56	1.49	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	30.20	8.33	3.12	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	29.35	10.78	1.99	0.14
Endothelial Cells - Thoracic, donor1	11266-116G6	36.41	19.21	4.40	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	62.89	8.91	3.14	1.57
Endothelial Cells - Umbilical vein, donor1	11243-116E1	36.90	11.68	2.98	0.50
Endothelial Cells - Umbilical vein, donor2	11324-117E1	30.20	6.30	2.39	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	28.09	6.11	2.56	0.12
Endothelial Cells - Vein, donor1	11267-116G7	21.61	11.38	2.28	1.14
Endothelial Cells - Vein, donor2	11344-117G3	30.04	8.38	3.49	1.40
Endothelial Cells - Vein, donor3	11416-118F3	33.60	13.35	2.98	0.63
Eosinophils, donor1	12244-129H3	15.25	45.74	15.25	0.00
Eosinophils, donor2	12245-129H4	16.50	1.65	4.95	0.00
Eosinophils, donor3	12246-129H5	10.70	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	43.49	5.62	1.22	0.73
Esophageal Epithelial Cells, donor2	11587-120G3	41.60	4.16	4.16	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	65.08	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	76.36	6.98	1.64	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	69.74	5.04	3.72	1.42
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	10.83	2.17	0.11	0.54
Fibroblast - Aortic Adventitial, donor1	11245-116E3	52.51	5.82	1.82	0.85
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	130.06	9.42	4.91	1.77
Fibroblast - Aortic Adventitial, donor2	11326-117E3	67.61	4.85	1.48	1.27
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	241.36	10.54	6.32	1.58
Fibroblast - Aortic Adventitial, donor3	11401-118D6	54.81	6.31	0.66	0.33
Fibroblast - Cardiac, donor1	11268-116G8	48.54	5.44	1.36	1.81
Fibroblast - Cardiac, donor2	11345-117G4	37.14	6.06	0.76	0.76
Fibroblast - Cardiac, donor3	11417-118F4	80.91	9.62	3.47	1.26
Fibroblast - Cardiac, donor4	11452-119A3	43.34	4.55	0.61	0.00
Fibroblast - Cardiac, donor5	11456-119A7	33.63	3.93	1.52	0.38
Fibroblast - Cardiac, donor6	11460-119B2	33.96	4.85	0.61	0.15
Fibroblast - Choroid Plexus, donor1	11492-119E7	77.04	4.96	0.80	0.13
Fibroblast - Choroid Plexus, donor2	11572-120E6	53.93	4.31	0.43	0.86
Fibroblast - Choroid Plexus, donor3	11653-122E6	87.89	7.32	1.46	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	69.42	7.84	1.85	0.46
Fibroblast - Conjunctival, donor3	11692-122I9	41.21	7.29	0.68	0.17
Fibroblast - Dermal, donor1	11269-116G9	35.92	3.05	1.88	1.17
Fibroblast - Dermal, donor2	11346-117G5	30.66	6.13	1.89	0.47
Fibroblast - Dermal, donor3	11418-118F5	31.31	4.47	0.97	0.12
Fibroblast - Dermal, donor4	11450-119A1	26.90	3.50	0.23	0.11
Fibroblast - Dermal, donor5	11454-119A5	22.85	2.97	0.35	0.35
Fibroblast - Dermal, donor6	11458-119A9	24.53	4.06	0.97	0.16
Fibroblast - Gingival, donor1	11237-116D4	41.23	6.46	1.25	0.83
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	57.38	7.60	2.10	0.52
Fibroblast - Gingival, donor2	11318-117D4	28.86	4.88	1.19	0.13
Fibroblast - Gingival, donor3	11394-118C8	35.00	7.06	0.77	0.39
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	51.94	9.35	1.04	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	40.70	4.23	1.41	0.53
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	31.18	8.11	1.87	0.31
Fibroblast - Gingival, donor6 (control)	11922-125H5	24.07	9.06	1.62	0.41
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	21.53	3.18	0.35	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	35.24	9.36	1.90	0.88
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	41.18	9.00	1.91	0.27
Fibroblast - Gingival, donor8 (control)	11926-125H9	28.63	4.50	1.10	0.22
Fibroblast - Gingival, donor9 (control)	11927-125I1	48.42	7.04	0.29	0.44
Fibroblast - Lung, donor1	11270-116H1	39.42	2.72	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	32.83	7.46	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	39.46	5.06	1.90	0.21
Fibroblast - Lymphatic, donor1	11506-119G3	116.62	13.33	2.50	1.67
Fibroblast - Lymphatic, donor2	11586-120G2	44.76	4.20	5.59	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	77.53	11.20	1.96	0.56
Fibroblast - Mammary, donor1	11540-120B1	57.65	8.12	1.62	1.22
Fibroblast - Mammary, donor2	11620-122A9	63.91	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	11.91	5.96	5.96	5.96
Fibroblast - Periodontal Ligament, donor1	11238-116D5	34.53	6.21	0.58	0.19
Fibroblast - Periodontal Ligament, donor2	11319-117D5	27.76	2.58	0.46	0.15
Fibroblast - Periodontal Ligament, donor3	11395-118C9	34.58	8.87	1.84	0.61
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	36.25	6.87	1.91	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	45.63	5.94	2.70	0.27
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	51.61	4.64	2.20	0.70
Fibroblast - Pulmonary Artery, donor1	11250-116E8	39.57	3.21	2.87	0.66
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	61.36	15.65	3.25	0.81
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	37.42	4.68	2.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	45.47	3.16	2.37	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	108.75	15.48	6.55	0.99
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	69.98	6.04	1.78	0.53
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	62.87	7.49	1.38	0.59
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	120.04	18.95	8.12	2.41
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	46.85	9.07	1.51	0.43
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	124.01	11.14	5.06	1.01
Fibroblast - skin normal, donor1	11553-120C5	99.43	16.24	3.94	1.80
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	125.52	20.45	13.43	1.00
Fibroblast - skin normal, donor2	11561-120D4	67.91	9.74	3.11	1.31
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	98.53	10.58	4.84	1.51
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	51.03	6.38	1.16	0.33
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	55.56	7.18	0.85	0.34
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	171.77	14.12	9.85	1.97
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	61.14	11.72	2.13	0.53
Fibroblast - skin walker warburg, donor1	11554-120C6	34.92	9.28	1.86	0.67
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	51.59	12.70	4.55	0.63
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	0.00	22.16	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	22.66	3.49	1.74	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	32.07	8.32	2.60	2.77
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	30.19	7.03	1.30	1.30
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	30.92	5.88	1.79	1.02
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	21.44	3.06	0.00	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	25.52	3.19	0.64	1.28
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	32.23	5.13	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	56.53	2.76	0.83	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	47.49	2.97	0.46	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	35.47	4.76	0.00	0.20
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	52.34	1.59	0.79	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	50.55	4.24	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	28.30	6.19	0.88	0.44
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	23.04	4.24	0.14	0.14
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	33.37	4.19	0.74	0.62
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	24.18	2.95	0.27	0.27
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	25.03	5.95	0.99	0.50
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	18.55	4.43	0.69	0.28
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	16.06	2.44	0.61	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	40.84	3.65	1.37	0.23
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	22.42	7.22	1.25	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	31.04	6.12	0.44	0.44
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	46.98	7.39	0.59	0.59
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	29.25	6.20	0.48	0.32
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	26.36	4.92	0.22	0.67
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	35.08	6.65	0.40	1.01
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	32.74	5.94	0.51	0.68
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	35.03	7.27	0.80	0.44
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	38.29	10.82	0.83	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	45.77	8.20	0.68	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	33.53	6.64	1.22	0.22
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	37.85	7.07	1.25	1.08
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	41.24	5.72	0.82	0.20
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	38.79	7.22	0.21	0.21
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	33.20	6.69	0.46	0.58
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	38.02	7.00	1.00	0.50
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	36.59	6.61	0.66	0.22
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	31.73	7.50	0.98	0.74
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	37.12	5.51	1.30	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	45.22	9.62	0.32	0.64
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	30.32	8.81	1.33	0.66
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	31.79	9.65	0.63	0.63
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	40.14	7.91	0.30	0.61
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	34.39	5.96	1.57	0.84
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	43.69	9.44	0.44	1.10
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	43.49	5.05	1.96	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	31.29	3.70	0.74	1.11
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	33.16	5.88	1.34	1.34
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	33.81	6.89	1.84	1.38
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	26.56	5.70	1.81	1.42
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	35.51	8.67	1.63	0.27
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	44.06	7.56	0.55	0.55
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	43.20	7.68	0.66	0.66
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	19.83	5.95	0.00	1.98
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	44.06	6.20	0.92	0.79
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	44.59	6.05	0.81	0.81
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	45.24	8.13	0.25	1.02
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	30.06	6.37	0.40	0.20
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	28.50	2.47	0.15	0.46
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	28.23	3.48	0.20	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	22.53	3.44	0.94	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	19.50	3.11	0.28	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	21.22	3.69	0.00	0.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	24.75	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	30.94	2.71	1.16	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	32.09	1.60	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	39.99	0.00	1.74	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	19.53	1.30	0.00	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	24.30	4.12	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	33.32	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	25.73	2.52	0.56	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	31.70	4.25	0.33	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	37.75	5.87	0.00	1.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	34.35	4.13	1.27	0.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	28.87	2.72	0.68	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	35.50	10.44	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	33.22	2.86	0.00	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	31.08	4.14	0.30	0.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	27.11	3.39	3.39	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	31.89	4.56	0.00	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	30.38	2.99	0.46	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	26.34	10.54	0.00	5.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	30.37	0.38	0.38	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	31.62	4.89	0.33	1.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	26.08	12.71	0.67	2.01
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	30.44	7.32	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	31.15	4.45	0.68	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	24.85	4.97	2.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	44.35	8.97	0.00	0.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	32.59	7.24	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	31.54	4.58	2.54	1.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	38.29	7.98	0.80	1.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	35.03	4.93	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	36.59	3.54	1.18	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	46.68	8.75	0.58	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	50.03	10.97	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	27.97	4.24	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	37.01	4.18	0.00	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	24.75	4.85	0.97	2.91
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	58.21	4.57	1.14	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	81.50	8.32	2.49	1.25
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	43.85	13.49	1.12	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	43.45	0.95	0.32	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	53.47	4.18	1.25	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	31.68	6.50	0.93	0.93
Hep-2 cells mock treated, biol_rep2	11899-125E9	31.90	5.23	1.01	0.68
Hep-2 cells mock treated, biol_rep3	11900-125F1	33.22	4.32	1.14	0.68
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	28.64	4.92	1.31	1.64
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	32.02	6.45	1.50	0.64
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	26.48	3.66	1.51	0.43
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	29.39	5.23	0.87	1.37
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	27.28	4.29	1.03	1.20
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	28.51	5.77	0.32	0.96
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	40.85	7.83	0.56	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	54.53	8.22	2.16	0.43
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	42.30	5.29	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	75.84	11.99	3.53	1.06
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	61.03	6.54	2.18	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	44.58	5.07	1.40	0.52
Hepatocyte, donor1	11523-119I2	52.06	3.63	0.00	0.00
Hepatocyte, donor2	11603-120I1	24.78	10.77	2.15	1.08
Hepatocyte, donor3	11684-122I1	50.92	4.29	2.45	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	50.91	9.79	0.00	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	40.55	3.50	1.40	0.35
Iris Pigment Epithelial Cells, donor1	11530-119I9	61.06	8.10	1.37	1.65
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	63.68	12.74	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	40.05	13.35	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	54.17	0.00	27.08	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	29.07	0.00	0.00	1.38
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	30.03	7.51	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	23.74	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	38.44	2.56	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	50.28	4.57	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	35.74	3.25	0.00	1.62
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	35.01	1.67	0.00	1.67
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	32.68	0.00	7.26	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	45.00	6.62	2.65	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	31.04	1.11	1.11	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	62.86	31.43	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	37.79	2.52	2.52	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	34.03	3.09	1.55	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	39.41	12.27	1.94	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	54.74	6.44	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	71.69	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	48.89	8.15	1.63	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	44.50	8.82	0.84	1.26
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	43.12	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	37.77	5.63	0.80	0.80
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	50.78	3.69	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	15.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	27.38	3.78	1.42	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	24.49	4.53	1.81	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	14.74	14.74	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	32.28	11.84	2.15	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	55.90	6.35	2.54	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	65.72	16.43	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	51.65	8.29	2.55	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	58.33	3.65	1.82	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	15.80	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	47.13	6.43	3.57	1.43
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	43.14	0.00	6.64	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	62.55	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	29.63	5.56	0.62	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	57.95	1.76	5.27	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	53.43	15.72	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	49.37	6.26	3.48	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	57.54	13.28	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	42.15	9.73	3.24	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	50.57	7.85	3.49	0.87
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	62.99	11.25	2.25	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	80.15	10.45	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	56.54	11.73	5.33	1.07
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	45.72	5.54	1.39	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	54.14	11.40	5.70	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	35.90	11.05	0.92	0.92
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	90.76	15.13	3.03	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	80.71	6.21	6.21	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	57.10	9.52	2.11	1.06
Keratinocyte - epidermal, donor1	11272-116H3	35.41	3.51	0.98	0.49
Keratinocyte - epidermal, donor2	11349-117G8	22.25	4.69	0.59	1.17
Keratinocyte - epidermal, donor3	11421-118F8	26.41	2.65	0.47	0.19
Keratinocyte - oral, donor1	11251-116E9	56.42	3.18	0.91	0.00
Keratocytes, donor1	11527-119I6	41.95	9.97	1.03	0.00
Keratocytes, donor2	11607-120I5	41.01	8.20	2.34	0.00
Keratocytes, donor3	11688-122I5	33.39	2.96	0.59	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	57.15	2.20	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	40.99	4.31	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	54.32	4.50	0.58	0.23
Lens Epithelial Cells, donor3	11690-122I7	146.02	7.37	3.13	1.01
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	34.86	11.03	0.95	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	24.28	5.86	0.84	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	25.66	8.03	0.94	0.47
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	30.11	6.99	1.61	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	24.27	7.88	0.32	0.63
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	21.13	7.22	1.29	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	25.85	8.21	0.82	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	24.02	10.87	2.53	0.25
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	22.94	7.46	1.41	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	24.13	10.28	2.77	1.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	21.52	11.25	1.36	0.58
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	24.44	9.44	0.93	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	25.78	6.97	1.74	1.05
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	23.61	9.54	0.48	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	24.72	6.73	1.24	0.27
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	27.41	5.85	2.16	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	19.95	9.66	1.25	0.94
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	31.11	7.50	2.01	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	28.96	5.92	1.32	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	26.94	9.96	2.05	0.29
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	33.61	9.71	0.75	0.75
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	24.73	5.33	3.39	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	19.66	10.50	0.81	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	26.34	9.08	1.51	0.15
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	29.03	7.78	1.04	0.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	20.52	7.54	1.88	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	25.86	8.72	1.95	0.15
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	27.52	8.25	2.75	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	23.52	6.40	0.75	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	29.05	9.12	1.59	0.32
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	24.23	11.15	0.48	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	21.50	10.25	1.65	0.66
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	24.28	7.43	0.87	0.62
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	31.47	9.26	1.85	0.74
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	20.26	6.92	0.74	0.49
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	24.75	7.70	1.79	0.55
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	25.73	5.15	1.29	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	17.96	10.96	1.22	0.61
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	28.55	8.26	0.98	0.14
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	22.76	7.82	1.07	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	19.88	11.15	0.48	1.45
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	29.10	9.49	2.96	0.16
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	22.56	7.88	1.43	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	26.46	8.82	1.31	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	31.55	9.42	2.35	0.47
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	27.23	11.88	1.98	1.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	20.49	12.29	2.31	0.51
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	27.15	7.46	0.60	0.60
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	47.59	18.13	0.00	6.80
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	91.29	12.27	1.53	2.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	63.83	7.42	2.97	3.71
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	63.47	13.54	0.85	0.85
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	71.04	7.03	2.11	1.41
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	74.72	15.88	0.93	3.74
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	56.68	12.37	2.06	2.06
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	70.18	15.46	4.76	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	61.07	16.29	1.58	1.13
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	59.33	9.02	0.87	1.74
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	56.72	10.35	2.70	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	75.06	21.68	2.03	2.85
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	69.33	13.87	1.54	3.08
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	52.58	13.76	2.47	2.82
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	53.97	13.33	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	50.94	12.73	3.06	1.53
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	57.63	13.61	2.67	1.60
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	59.90	11.53	0.76	2.65
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	58.90	6.75	1.23	3.68
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	57.90	14.68	2.45	1.63
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	46.02	10.41	1.46	2.50
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	53.53	10.65	1.12	2.24
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	64.91	11.33	0.00	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	49.93	12.48	1.16	0.87
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	57.69	10.46	1.20	2.09
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	59.75	8.30	1.11	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	61.86	19.09	0.35	0.35
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	49.05	12.17	0.74	1.48
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	57.56	9.21	1.15	1.15
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	58.71	9.21	1.15	3.84
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	64.54	19.81	1.13	1.70
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	60.71	13.13	1.64	1.64
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	63.26	12.20	0.90	1.36
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	63.91	8.62	2.15	1.44
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	56.76	14.19	0.75	2.24
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	66.14	13.38	1.49	1.49
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	41.78	9.05	1.29	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	60.80	7.71	0.86	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	63.30	14.99	1.67	1.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	60.33	15.69	1.21	1.81
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	68.26	10.66	1.42	3.55
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	47.09	11.69	1.37	2.41
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	65.48	8.05	1.61	1.07
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	68.68	11.45	2.69	1.35
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	58.89	12.22	0.37	0.74
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	39.54	12.79	0.00	2.33
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	53.94	11.64	1.06	2.12
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	52.42	12.40	2.40	1.60
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	64.69	18.90	0.73	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	74.35	13.03	2.30	4.60
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	74.98	14.80	1.48	0.99
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	61.16	13.17	0.94	0.94
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	71.90	14.08	2.01	3.52
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	67.14	14.87	1.80	0.90
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	55.08	5.16	1.72	1.72
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	68.14	13.81	0.45	0.89
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	62.96	13.69	1.56	0.78
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	54.10	9.90	1.32	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	60.71	10.90	1.04	1.56
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	62.57	13.56	1.31	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	52.00	11.74	1.12	1.12
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	60.06	12.37	2.21	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	66.73	15.43	0.77	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	55.19	12.66	2.53	2.53
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	62.00	10.57	1.44	2.40
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	64.80	11.93	1.19	1.59
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	55.29	16.41	1.82	1.22
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	44.27	8.99	2.08	2.77
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	55.10	11.78	1.90	3.04
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	54.22	12.39	1.03	1.55
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	66.51	9.67	1.21	3.63
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	60.53	9.82	1.27	1.27
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	59.17	12.79	1.60	1.60
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	76.43	10.92	1.72	2.30
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	75.59	15.43	1.54	2.06
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	55.17	10.61	0.71	1.41
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	63.56	10.78	2.84	2.27
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	61.99	15.39	0.83	1.66
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	70.47	8.61	0.78	3.13
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	60.13	5.85	1.25	1.67
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	60.87	11.15	0.46	0.46
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	54.19	11.37	0.00	1.34
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	62.55	9.09	1.07	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	65.46	11.72	1.62	0.40
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	59.65	12.85	2.75	0.92
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	56.90	6.22	2.67	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	58.70	9.12	0.00	4.56
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	55.22	11.50	2.30	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	61.83	7.11	1.09	1.09
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	50.78	7.13	1.34	1.78
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	67.07	14.30	1.30	1.56
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	53.05	5.97	3.32	3.98
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	89.38	14.55	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	26.21	11.62	1.82	0.68
Macrophage - monocyte derived, donor2	11313-117C8	22.20	8.99	0.92	0.92
Macrophage - monocyte derived, donor3	11389-118C3	24.51	8.52	1.44	0.66
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	21.24	5.31	2.66	0.53
Mallassez-derived cells, donor2	11929-125I3	48.80	12.52	3.17	2.06
Mallassez-derived cells, donor3	11930-125I4	26.55	5.98	2.50	0.97
Mammary Epithelial Cell, donor1	11273-116H4	37.07	9.27	1.79	0.60
Mammary Epithelial Cell, donor2	11350-117G9	35.33	6.08	2.61	0.29
Mammary Epithelial Cell, donor3	11422-118F9	25.19	5.74	0.50	0.75
Mast cell - stimulated, donor1	11487-119E2	8.14	4.07	0.00	0.00
Mast cell, donor1	11563-120D6	22.28	7.89	0.32	0.11
Mast cell, donor2	11565-120D8	23.18	7.73	0.59	0.00
Mast cell, donor3	11566-120D9	24.09	5.85	0.90	0.45
Mast cell, donor4	11567-120E1	25.53	7.45	1.24	0.53
Mast cell, expanded and stimulated, donor5	11940-126A5	24.95	6.32	0.33	0.44
Mast cell, expanded and stimulated, donor8	11942-126A7	18.68	8.17	0.58	1.75
Mast cell, expanded, donor5	11939-126A4	20.42	6.77	0.46	0.11
Mast cell, expanded, donor8	11941-126A6	23.10	6.86	0.84	0.17
Melanocyte - dark, donor1	11502-119F8	27.16	11.04	2.29	0.30
Melanocyte - dark, donor2	11582-120F7	39.11	5.88	2.08	1.04
Melanocyte - dark, donor3	11663-122F7	49.19	6.01	1.23	0.65
Melanocyte - light, donor1	11274-116H5	41.37	9.87	1.88	0.47
Melanocyte - light, donor2	11351-117H1	39.58	9.55	1.36	1.36
Melanocyte - light, donor3	11423-118G1	24.28	4.34	1.73	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	36.44	3.23	1.04	0.42
Melanocyte, donor2 (MC+2)	12739-135I3	45.72	6.99	0.00	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	25.18	5.36	0.54	0.80
Meningeal Cells, donor1	11493-119E8	63.89	6.70	1.24	0.37
Meningeal Cells, donor2	11573-120E7	56.34	3.96	2.20	0.00
Meningeal Cells, donor3	11654-122E7	38.14	3.91	0.82	0.16
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	34.22	5.99	1.14	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	77.29	7.04	2.21	1.31
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	64.39	11.83	0.00	1.31
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	58.87	10.47	1.31	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	33.01	3.59	1.44	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	52.94	7.84	1.69	1.06
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	49.26	8.54	2.01	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	59.99	6.15	1.10	0.88
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	35.80	5.84	2.19	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	50.74	6.14	0.82	1.02
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	74.93	5.82	0.69	0.28
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	98.14	9.29	1.12	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	56.84	5.00	0.79	0.39
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	52.52	12.17	2.67	1.19
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	58.39	2.34	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	69.16	8.33	1.28	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	39.34	4.61	1.77	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	55.04	5.94	1.25	0.63
Mesenchymal stem cells - umbilical, donor0	11214-116A8	43.54	4.35	0.73	4.35
Mesothelial Cells, donor1	11247-116E5	73.72	4.51	4.24	1.33
Mesothelial Cells, donor2	12156-128G5	67.56	5.51	1.00	1.50
Mesothelial Cells, donor3	11402-118D7	46.47	5.71	2.75	0.79
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	28.36	12.15	2.70	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	25.86	10.34	1.48	1.48
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	26.21	7.07	2.06	2.06
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	20.74	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	13.02	7.75	0.93	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	24.06	8.09	1.87	0.83
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	9.26	4.63	0.00	2.32
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	21.52	11.01	1.25	2.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	30.26	9.78	0.93	1.86
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	58.40	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	22.76	8.74	1.42	0.61
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	27.32	7.13	1.58	1.19
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	42.76	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	18.58	12.39	1.77	2.65
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	29.26	7.98	1.52	1.52
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	19.74	1.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	18.46	9.76	0.42	1.06
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	16.57	4.60	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	15.20	5.96	0.89	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	10.06	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	33.95	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	16.31	6.77	1.00	1.51
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	20.20	5.23	0.24	0.71
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	8.85	2.21	0.00	1.66
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	19.34	7.14	0.69	0.46
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	20.40	4.84	0.42	1.47
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	10.60	4.28	0.61	1.02
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	16.73	5.79	0.64	0.43
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	18.67	6.22	0.89	1.33
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	10.32
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	16.65	5.26	1.10	0.66
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	14.19	5.07	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	3.31	0.00	0.00	1.66
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	10.06	5.44	0.82	0.54
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	18.82	6.76	0.59	1.18
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	6.54	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	11.05	2.88	1.92	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	18.41	2.80	0.40	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	8.23	1.37	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	11.01	2.50	0.00	0.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	8.15	4.08	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	12.26	5.26	0.00	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	11.04	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	7.04	1.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	11.90	3.22	0.50	1.24
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	12.53	1.39	0.70	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	6.63	0.00	2.21	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	11.97	5.47	1.03	1.03
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	12.69	2.19	0.88	0.88
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	7.10	4.62	0.00	0.36
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	13.75	5.61	1.96	0.56
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	11.22	3.74	0.83	1.25
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	12.24	2.91	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	11.76	5.43	0.60	1.21
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	14.19	4.17	0.42	1.25
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	14.44	7.22	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	10.16	4.62	0.92	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	18.21	3.98	1.14	1.14
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	12.57	6.49	1.52	0.55
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	13.48	4.92	0.52	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	16.30	9.01	0.86	0.86
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	8.89	5.72	0.00	0.64
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	11.21	4.00	1.33	1.07
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	22.75	5.99	1.80	0.60
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	11.87	4.66	1.84	0.71
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	15.61	6.37	1.59	0.32
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	17.03	10.39	2.65	1.33
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	19.34	4.55	1.14	0.76
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	16.19	6.82	0.85	1.70
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	16.22	6.88	3.69	1.72
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	27.37	2.61	0.65	1.30
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	22.64	6.47	2.65	0.29
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	25.08	5.77	1.73	2.02
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	25.14	11.95	0.00	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	25.91	4.47	1.49	0.60
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	3.77	18.83	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	19.60	19.60	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	16.10	12.49	2.63	0.99
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	17.88	14.73	1.05	1.05
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	19.37	13.64	1.58	0.40
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	19.56	15.83	1.86	2.79
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	20.65	12.02	1.13	0.75
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	22.91	13.85	1.60	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	14.25	10.74	0.68	0.45
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	16.21	13.26	1.47	1.47
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	19.05	10.26	0.73	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	15.56	12.44	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	5.34	5.88	0.53	0.53
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	23.18	11.59	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	23.23	15.15	4.04	3.03
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	13.07	8.01	0.42	0.84
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	2.72	0.00	1.36	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	0.64	0.64	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	0.81	0.00	0.81	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	1.51	0.00	0.00	3.02
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	5.71	5.71	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	13.05	0.00	0.00	3.26
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	9.50	0.00	4.75	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	25.10	0.00	12.55	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	65.71	6.03	1.29	2.15
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	68.46	1.57	2.09	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	43.39	7.34	4.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	28.80	4.17	1.25	1.25
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	22.44	5.32	4.37	1.52
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	51.07	14.36	4.79	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	38.76	2.04	2.04	0.68
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	14.70	9.19	3.68	1.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	51.06	7.12	0.84	1.67
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	38.12	5.11	2.79	0.70
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	36.75	3.78	1.08	0.81
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	47.09	6.10	2.94	1.89
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	33.40	11.13	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	46.16	8.44	3.47	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	38.16	7.04	2.44	0.54
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	31.51	5.67	1.59	0.68
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	31.68	2.61	0.82	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	36.45	4.74	1.82	1.09
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	50.39	4.77	2.12	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	55.83	7.20	2.40	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	18.05	10.50	3.28	0.98
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	28.46	3.09	1.79	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	41.63	3.35	1.41	1.41
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	48.52	2.11	2.11	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	39.99	5.98	3.22	1.84
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	50.77	5.78	1.93	0.64
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	29.32	6.90	1.38	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	17.70	2.53	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	40.10	3.34	1.11	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	33.02	3.81	0.42	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	30.38	3.56	1.42	0.24
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	60.09	5.15	0.43	3.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	27.08	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	53.98	5.33	1.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	31.56	3.16	0.45	0.90
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	28.57	2.38	1.19	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	47.36	4.64	0.00	1.86
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	50.32	4.54	1.89	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	39.76	2.61	0.98	1.63
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	56.22	2.18	0.00	0.87
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	38.44	2.26	0.45	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	37.92	4.41	0.00	0.88
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	55.18	6.65	0.66	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	60.02	3.97	1.49	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	40.20	1.15	0.38	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	86.50	3.02	0.91	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	44.65	1.99	1.11	0.44
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	52.86	2.03	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	10.22	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	67.06	2.44	1.22	0.61
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	45.01	2.52	0.31	0.63
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	44.19	1.21	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	47.47	3.16	0.79	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	49.88	6.80	1.13	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	15.17	0.00	5.06	0.00
Myoblast, donor1	11241-116D8	57.39	7.08	2.36	1.12
Myoblast, donor2	11322-117D8	55.62	7.48	1.73	1.53
Myoblast, donor3	11398-118D3	61.88	10.09	2.02	3.03
NK T cell leukemia cell line:KHYG-1	10777-110G3	33.56	7.00	1.31	0.44
Natural Killer Cells, donor1	11230-116C6	30.44	9.23	1.23	0.62
Natural Killer Cells, donor2	11311-117C6	27.14	5.73	0.90	0.90
Natural Killer Cells, donor3	11387-118C1	29.63	6.99	1.29	0.55
Neural stem cells, donor1	11275-116H6	60.25	6.53	0.36	0.36
Neural stem cells, donor2	11352-117H2	44.29	3.85	0.00	0.00
Neurons, donor1	11494-119E9	39.83	2.28	1.14	0.00
Neurons, donor2	11574-120E8	43.59	2.42	0.22	0.22
Neurons, donor3	11655-122E8	23.02	3.29	1.64	0.00
Neutrophils, donor1	11233-116C9	5.57	5.57	0.93	1.86
Neutrophils, donor2	11314-117C9	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	4.89	3.67	0.00	0.61
Nucleus Pulposus Cell, donor1	11252-116F1	48.80	9.02	0.71	0.24
Nucleus Pulposus Cell, donor2	11409-118E5	67.07	5.86	0.65	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	34.70	3.61	0.40	0.00
Olfactory epithelial cells, donor1	11933-125I7	22.44	5.23	0.83	0.28
Olfactory epithelial cells, donor2	11934-125I8	35.03	4.34	1.01	0.29
Olfactory epithelial cells, donor3	11935-125I9	36.55	6.81	1.14	0.68
Olfactory epithelial cells, donor4	11936-126A1	38.47	8.86	1.17	0.49
Oligodendrocyte - precursors, donor1	11496-119F2	34.30	9.63	1.81	0.60
Osteoblast - differentiated, donor1	11276-116H7	66.57	2.98	0.64	0.85
Osteoblast - differentiated, donor2	11353-117H3	83.45	5.72	3.43	3.43
Osteoblast - differentiated, donor3	11425-118G3	50.90	4.97	1.24	0.62
Osteoblast, donor1	11277-116H8	89.71	10.16	2.54	1.17
Osteoblast, donor2	11354-117H4	55.48	7.02	2.11	1.40
Osteoblast, donor3	11426-118G4	59.90	7.82	2.31	1.78
Pancreatic stromal cells, donor1	11249-116E7	42.37	8.09	1.60	0.93
Pericytes, donor1	11491-119E6	78.22	5.01	0.45	0.22
Pericytes, donor2	11571-120E5	65.19	4.30	0.68	0.00
Pericytes, donor3	11652-122E5	66.32	6.51	1.63	1.02
Perineurial Cells, donor1	11499-119F5	72.22	4.07	1.24	0.45
Perineurial Cells, donor2	11579-120F4	47.39	7.73	2.21	0.55
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	23.59	12.11	0.96	0.64
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	14.45	9.55	0.24	0.49
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	21.61	11.13	1.29	0.52
Placental Epithelial Cells, donor1	11278-116H9	48.31	8.13	3.11	0.96
Placental Epithelial Cells, donor2	11355-117H5	66.53	22.18	2.22	1.11
Placental Epithelial Cells, donor3	11427-118G5	56.93	10.99	1.96	1.18
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	74.05	5.70	3.48	1.90
Preadipocyte - breast, donor1	11467-119B9	90.98	9.38	2.25	1.13
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	108.73	7.57	2.74	0.39
Preadipocyte - breast, donor2	11328-117E5	94.34	7.43	1.80	0.90
Preadipocyte - omental, donor1	11468-119C1	121.90	10.76	3.30	2.02
Preadipocyte - omental, donor2	11329-117E6	80.31	9.60	0.87	0.44
Preadipocyte - omental, donor3	11403-118D8	97.55	4.87	3.15	0.86
Preadipocyte - perirenal, donor1	11469-119C2	90.55	8.86	0.98	2.95
Preadipocyte - subcutaneous, donor1	11279-116I1	46.99	7.99	1.54	1.54
Preadipocyte - subcutaneous, donor2	11356-117H6	45.33	7.61	4.25	0.89
Preadipocyte - subcutaneous, donor3	11428-118G6	82.59	12.09	4.94	1.53
Preadipocyte - visceral, donor1	11280-116I2	59.06	8.66	2.89	0.84
Preadipocyte - visceral, donor2	11357-117H7	41.42	8.74	1.38	0.00
Preadipocyte - visceral, donor3	11429-118G7	54.13	7.63	2.19	0.84
Prostate Epithelial Cells (polarized), donor1	11253-116F2	25.80	2.72	1.36	0.60
Prostate Epithelial Cells, donor2	11331-117E8	34.53	3.11	0.54	0.68
Prostate Epithelial Cells, donor3	11404-118D9	23.94	0.86	0.24	0.12
Prostate Stromal Cells, donor1	11254-116F3	57.98	6.26	1.48	1.25
Prostate Stromal Cells, donor2	11332-117E9	52.53	7.35	1.79	0.36
Prostate Stromal Cells, donor3	11405-118E1	52.35	6.36	1.56	0.83
Renal Cortical Epithelial Cells, donor1	11516-119H4	48.18	7.66	0.73	0.73
Renal Cortical Epithelial Cells, donor2	11596-120H3	31.81	4.78	0.55	0.28
Renal Epithelial Cells, donor1	11517-119H5	77.61	17.75	3.04	1.01
Renal Epithelial Cells, donor2	11597-120H4	46.95	7.82	1.42	1.42
Renal Epithelial Cells, donor3	11678-122H4	52.51	8.26	1.27	0.74
Renal Glomerular Endothelial Cells, donor1	11514-119H2	45.62	15.66	4.77	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	34.23	11.32	2.96	0.81
Renal Glomerular Endothelial Cells, donor3	11675-122H1	43.07	6.88	3.55	0.44
Renal Glomerular Endothelial Cells, donor4	11783-124B1	67.88	13.97	2.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	88.04	10.12	2.86	1.54
Renal Mesangial Cells, donor2	11598-120H5	68.34	11.29	3.13	3.13
Renal Mesangial Cells, donor3	11679-122H5	71.57	9.43	0.55	1.66
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	38.92	10.74	1.61	0.81
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	32.05	9.70	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	30.28	5.98	0.77	1.35
Retinal Pigment Epithelial Cells, donor0	11215-116A9	25.41	3.63	0.52	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	61.40	10.23	1.14	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	37.05	7.20	2.06	1.03
Retinal Pigment Epithelial Cells, donor3	11689-122I6	41.65	4.77	0.50	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	36.08	3.74	1.07	0.53
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	83.09	2.68	0.00	1.79
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	43.48	6.60	2.75	1.10
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	48.72	5.80	1.74	1.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	68.26	8.71	0.52	0.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	66.93	6.65	1.49	1.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	71.83	10.71	1.23	1.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	71.82	6.20	1.12	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	71.21	8.39	1.05	1.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	67.72	12.48	1.39	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	61.61	6.16	1.92	1.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	58.85	7.11	1.21	1.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	77.41	11.47	2.69	1.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	68.72	6.31	2.15	1.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	66.86	6.55	1.50	0.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	62.40	5.31	1.55	1.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	68.06	4.78	1.53	1.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	58.04	6.61	1.49	0.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	68.21	8.83	0.56	0.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	67.28	5.84	1.33	0.93
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	62.49	7.59	1.07	0.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	67.41	7.83	2.10	1.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	64.82	5.45	0.96	1.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	59.99	7.85	1.40	0.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	63.57	6.32	2.39	2.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	64.54	5.47	0.73	0.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	68.55	7.24	1.84	1.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	71.32	7.39	2.01	2.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	87.74	8.26	1.18	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	62.70	8.93	1.79	0.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	70.15	7.02	1.40	1.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	70.50	6.01	2.70	1.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	66.81	9.95	1.11	0.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	64.55	7.52	1.25	1.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	74.69	7.13	1.75	1.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	68.63	6.13	1.87	1.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	75.58	7.52	1.93	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	69.98	6.36	1.20	1.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	66.80	6.72	1.37	1.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	66.00	6.73	0.99	1.31
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	67.32	6.48	1.36	1.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	68.80	8.73	1.78	1.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	66.37	9.86	1.60	1.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	69.41	5.39	1.66	1.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	68.34	7.62	1.19	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	63.89	10.08	2.42	1.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	61.02	8.95	1.88	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	66.38	10.48	2.79	1.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	60.74	6.95	2.42	1.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	62.42	11.26	1.84	2.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	69.87	13.68	1.46	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	76.05	10.34	1.22	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	69.02	7.84	2.71	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	88.21	14.70	1.58	1.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	87.77	10.48	2.40	2.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	101.90	10.51	1.89	2.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	102.03	9.61	2.56	1.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	77.53	3.61	2.40	0.60
Schwann Cells, donor1	11498-119F4	66.58	8.65	0.56	0.00
Schwann Cells, donor2	11578-120F3	37.43	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	55.87	2.85	1.97	0.88
Sebocyte, donor1	11220-116B5	55.32	2.74	2.19	0.55
Sebocyte, donor2	11301-117B5	34.93	1.84	0.46	0.46
Sebocyte, donor3	11378-118B1	37.51	2.06	0.62	0.41
Sertoli Cells, donor1	11255-116F4	69.58	9.94	0.00	0.00
Sertoli Cells, donor2	11333-117F1	64.96	8.47	2.82	0.00
Skeletal Muscle Cells, donor1	11281-116I3	67.22	6.25	0.79	0.18
Skeletal Muscle Cells, donor2	11358-117H8	52.77	2.89	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	55.18	5.02	1.67	0.00
Skeletal Muscle Cells, donor4	11451-119A2	35.35	1.73	1.26	0.00
Skeletal Muscle Cells, donor5	11455-119A6	30.32	1.04	1.04	0.30
Skeletal Muscle Cells, donor6	11459-119B1	30.63	3.23	0.15	0.15
Skeletal Muscle Satellite Cells, donor1	11240-116D7	49.02	6.80	1.01	0.25
Skeletal Muscle Satellite Cells, donor2	11321-117D7	43.38	3.71	0.43	0.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	36.21	2.78	0.50	0.20
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	65.97	4.21	0.67	0.42
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	34.02	7.24	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	61.78	8.12	2.34	0.41
Skin - palm, donor1	10286-104F7	34.92	0.00	2.69	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	20.18	3.46	2.16	0.43
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	95.69	9.81	9.81	1.64
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	17.92	3.89	1.69	0.52
Small Airway Epithelial Cells, donor1	11256-116F5	37.12	6.26	1.25	0.42
Small Airway Epithelial Cells, donor2	11334-117F2	28.13	5.77	1.83	0.84
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	80.14	15.22	4.23	0.85
Small Airway Epithelial Cells, donor3	11406-118E2	36.13	4.65	1.35	0.52
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	13.89	3.70	0.62	1.23
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	281.69	26.68	12.23	2.67
Smooth Muscle Cells - Aortic, donor0	11210-116A4	54.08	12.93	1.76	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	56.13	12.38	1.55	1.99
Smooth Muscle Cells - Aortic, donor2	11360-117I1	71.67	7.09	3.54	1.18
Smooth Muscle Cells - Aortic, donor3	11432-118H1	64.90	11.59	3.09	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	36.03	11.01	0.00	1.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	63.61	8.25	3.86	2.13
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	84.45	7.54	3.32	0.66
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	53.39	6.27	1.92	2.30
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	59.91	1.63	1.63	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	47.84	4.43	0.59	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	47.12	3.70	2.42	0.85
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	64.74	5.21	1.14	0.49
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	42.93	1.83	0.00	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	57.33	12.88	2.27	0.51
Smooth Muscle Cells - Carotid, donor2	11362-117I3	67.33	12.24	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	30.04	6.68	1.43	1.43
Smooth Muscle Cells - Colonic, donor1	11239-116D6	41.15	4.87	1.47	0.44
Smooth Muscle Cells - Colonic, donor2	11320-117D6	43.91	5.17	0.86	0.43
Smooth Muscle Cells - Colonic, donor3	11396-118D1	42.61	5.56	1.26	0.21
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	74.40	10.98	2.94	2.47
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	51.74	8.62	1.08	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	49.01	5.38	1.49	1.49
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	56.33	9.90	1.37	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	43.66	5.65	0.39	0.16
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	77.80	6.14	2.11	1.01
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	85.56	9.10	4.10	1.37
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	48.30	14.49	1.21	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	35.24	3.18	1.06	0.53
Smooth Muscle Cells - Prostate, donor1	11257-116F6	52.73	7.59	2.26	1.20
Smooth Muscle Cells - Prostate, donor2	11335-117F3	72.75	6.14	2.13	0.63
Smooth Muscle Cells - Prostate, donor3	11465-119B7	78.38	12.18	2.28	0.51
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	64.53	10.55	3.47	0.60
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	63.01	9.00	1.50	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	19.38	12.92	2.58	1.29
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	55.34	10.70	2.33	0.93
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	112.08	10.10	2.02	1.01
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	69.26	7.21	3.13	1.88
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	60.18	6.49	1.47	0.88
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	43.40	5.00	1.42	0.42
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	47.18	3.27	0.47	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	57.14	6.91	1.73	1.87
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	29.83	6.63	0.76	0.76
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	50.58	7.90	1.32	1.13
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	52.26	6.57	1.40	0.70
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	66.70	5.53	0.92	0.50
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	56.19	2.38	1.90	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	47.95	8.32	1.22	2.20
Smooth Muscle Cells - Uterine, donor1	11258-116F7	70.92	9.50	1.77	1.33
Smooth Muscle Cells - Uterine, donor3	11466-119B8	47.40	9.07	1.17	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	41.20	3.89	0.19	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	56.59	4.23	1.59	1.32
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	37.57	10.41	5.21	0.74
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	62.17	6.83	2.87	2.87
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	60.19	3.97	2.27	3.97
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	39.39	5.91	5.51	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	51.30	3.05	1.02	0.51
Smooth muscle cells - airway, control, donor2	11967-126D5	46.32	4.79	0.80	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	44.73	2.51	1.25	0.42
Smooth muscle cells - airway, control, donor4	11969-126D7	76.09	6.88	0.92	0.00
Synoviocyte, donor1	11291-117A4	51.17	4.21	1.18	0.50
Synoviocyte, donor2	11368-117I9	65.04	4.53	1.01	1.01
Synoviocyte, donor3	11440-118H9	50.27	5.14	1.34	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	43.59	7.86	0.71	0.36
Trabecular Meshwork Cells, donor2	11612-122A1	47.57	3.96	1.98	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	51.40	7.41	1.39	1.16
Tracheal Epithelial Cells, donor1	11292-117A5	33.19	4.52	0.57	0.57
Tracheal Epithelial Cells, donor2	11369-118A1	20.49	4.25	1.16	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	33.21	4.01	1.15	2.86
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	34.32	4.92	0.98	0.00
Urethra, donor2	10319-105A4	28.77	1.80	0.00	0.00
Urothelial Cells, donor1	11520-119H8	54.99	8.50	1.33	0.27
Urothelial Cells, donor2	11600-120H7	44.06	2.80	1.20	1.20
Urothelial Cells, donor3	11681-122H7	42.17	6.65	0.46	0.23
Urothelial cells, donor0	11216-116B1	55.50	7.13	1.11	0.45
Whole blood (ribopure), donor090309, donation1	12179-129A1	33.81	22.24	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	25.73	11.44	2.86	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	21.90	8.90	2.05	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	35.47	15.84	0.69	0.34
Whole blood (ribopure), donor090325, donation2	12177-128I8	32.54	19.17	1.16	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	32.28	13.54	2.08	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	31.20	12.85	0.92	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	20.08	7.30	1.83	0.00
Wilms' tumor cell line:G-401	10809-111A8	34.91	3.33	1.36	0.12
Wilms' tumor cell line:HFWT	10597-108E3	51.04	0.00	0.88	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	35.47	3.63	0.28	0.00
achilles tendon, donor2	10292-104G4	22.73	4.13	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	3.57	7.14	1.53	0.25
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	18.34	6.50	0.46	0.70
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	22.55	9.62	1.31	0.36
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	34.01	3.81	0.54	0.82
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	33.45	6.75	1.12	0.84
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	31.93	10.15	1.69	1.06
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	27.77	6.53	1.63	1.63
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	56.84	4.85	1.76	0.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	51.45	14.29	1.23	1.63
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	30.68	9.71	1.55	1.94
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	11.41	5.89	0.55	0.18
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	23.40	19.50	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	23.70	9.99	0.93	1.16
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	27.96	11.13	1.55	0.78
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	15.49	8.48	2.05	0.29
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	22.77	9.76	2.79	0.46
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	27.55	3.29	1.23	2.06
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	25.48	4.60	2.46	0.31
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	36.27	18.35	2.13	1.71
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	43.07	17.29	2.73	0.61
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	38.27	13.00	1.93	1.44
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	9.13	4.45	1.34	0.22
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	22.01	1.67	0.00	1.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	63.18	3.72	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	29.76	3.39	0.75	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	63.68	2.62	0.00	1.31
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	37.49	1.87	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	24.96	8.48	1.88	1.65
adipose tissue, adult, pool1	10010-101C1	25.90	5.89	0.78	0.31
adipose, donor1	10184-103D4	27.56	5.28	0.59	0.00
adipose, donor2	10185-103D5	53.53	1.22	0.00	0.41
adipose, donor3	10186-103D6	43.57	1.91	0.00	0.00
adipose, donor4	10187-103D7	23.40	6.07	0.00	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	43.56	0.00	0.00	0.47
adrenal gland, adult, pool1	10081-102A9	32.74	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	10.14	12.54	0.67	0.27
alveolar cell carcinoma cell line:SW 1573	10708-109H6	40.73	9.29	2.14	1.07
amniotic membrane cells, donor1	12235-129G3	47.99	8.58	0.23	0.23
amniotic membrane cells, donor2	12236-129G4	72.69	9.80	0.34	1.69
amniotic membrane cells, donor3	12237-129G5	45.96	4.71	0.59	0.29
amygdala - adult, donor10196	10167-103B5	54.55	0.00	1.19	0.00
amygdala, adult, donor10252	10151-102I7	44.81	1.22	0.41	0.20
amygdala, newborn, donor10223	10360-105E9	20.33	1.29	0.97	0.32
anaplastic carcinoma cell line:8305C	10428-106D5	66.85	8.40	1.02	0.38
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	23.17	5.29	1.54	0.66
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	54.45	6.35	0.00	0.67
aorta, adult, pool1	10052-101G7	25.50	4.90	0.78	0.20
appendix, adult	10189-103D9	23.68	6.99	0.39	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	30.61	10.32	0.69	1.03
artery, adult	10190-103E1	12.23	0.00	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	70.70	7.53	1.30	0.58
b cell line:RPMI1788	10427-106D4	11.75	12.04	0.15	0.15
basal cell carcinoma cell line:TE 354.T	10702-109G9	49.39	6.38	2.22	0.83
bile duct carcinoma cell line:HuCCT1	10432-106D9	25.90	7.74	0.79	0.60
bile duct carcinoma cell line:TFK-1	10496-107C1	19.42	1.84	0.00	0.33
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	14.54	11.74	0.00	0.00
bladder, adult, pool1	10011-101C2	22.49	1.74	0.22	0.22
blood, adult, pool1	10053-101G8	15.50	11.07	2.21	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	41.10	13.70	4.28	2.57
bone marrow, adult	10192-103E3	42.51	5.40	0.00	0.67
brain, adult, donor1	10084-102B3	48.18	3.08	0.00	1.03
brain, adult, pool1	10012-101C3	42.09	1.00	0.22	0.11
brain, fetal, pool1	10085-102B4	64.11	2.67	2.67	2.67
breast carcinoma cell line:MCF7	10482-107A5	65.08	7.60	1.65	0.33
breast carcinoma cell line:MDA-MB-453	10419-106C5	133.31	16.35	2.87	2.37
breast, adult, donor1	10080-102A8	14.52	2.53	1.26	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	24.14	5.84	0.89	0.38
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	63.39	10.51	2.47	0.62
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	33.61	12.20	0.23	0.23
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	43.58	5.08	0.24	0.73
carcinoid cell line:NCI-H1770	10703-109H1	19.28	2.82	0.00	0.00
carcinoid cell line:NCI-H727	10735-110B6	42.55	1.97	0.22	0.22
carcinoid cell line:SK-PN-DW	10719-109I8	34.86	4.44	0.63	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	55.63	5.86	1.33	0.00
caudate nucleus - adult, donor10196	10177-103C6	39.14	1.15	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	44.34	2.84	0.00	0.33
caudate nucleus, adult, donor10258	10379-105H1	48.14	0.76	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	25.27	1.10	0.00	0.00
cerebellum - adult, donor10196	10173-103C2	52.44	2.91	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	65.55	1.28	0.00	0.00
cerebellum, adult, pool1	10083-102B2	36.22	1.03	0.00	0.34
cerebellum, newborn, donor10223	10357-105E6	71.40	2.49	0.83	0.00
cerebral meninges, adult	10188-103D8	39.59	0.25	0.25	0.50
cerebrospinal fluid, donor2	10294-104G6	14.62	0.73	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	53.63	7.33	0.43	0.43
cervical cancer cell line:ME-180	10553-107I4	65.29	10.11	1.82	0.50
cervix, adult, pool1	10013-101C4	36.12	4.72	0.21	0.31
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	132.23	0.70	0.42	0.28
chondrosarcoma cell line:SW 1353	10700-109G7	92.74	5.23	2.61	3.92
choriocarcinoma cell line:BeWo	10423-106C9	58.16	22.25	2.11	0.50
choriocarcinoma cell line:SCH	10785-110H2	67.52	4.07	0.49	0.49
choriocarcinoma cell line:T3M-3	10618-108G6	49.10	8.78	0.47	0.47
chorionic membrane cells, donor1	12238-129G6	33.34	14.25	0.57	1.71
chorionic membrane cells, donor2	12239-129G7	59.46	16.11	2.98	0.80
chorionic membrane cells, donor3	12240-129G8	39.01	14.84	0.55	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	15.15	3.03	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	45.72	5.19	1.54	0.58
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	48.15	5.49	1.48	0.63
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	18.49	1.80	0.51	0.26
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	22.49	1.69	0.73	0.24
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	16.49	2.04	0.20	0.20
chronic myelogenous leukemia cell line:K562	10454-106G4	57.12	6.77	3.24	0.59
chronic myelogenous leukemia cell line:KU812	10409-106B4	33.88	4.95	1.04	0.26
clear cell carcinoma cell line:JHOC-5	10638-108I8	44.57	2.06	0.23	0.23
clear cell carcinoma cell line:TEN	10636-108I6	52.92	6.94	0.35	0.17
colon carcinoma cell line:CACO-2	10513-107D9	19.40	12.81	1.46	0.92
colon carcinoma cell line:COLO-320	10420-106C6	76.40	19.38	0.76	0.00
colon, adult, donor1	10082-102B1	30.94	7.14	0.00	0.00
colon, adult, pool1	10014-101C5	23.03	5.41	0.71	0.35
colon, fetal, donor1	10070-101I7	33.99	3.09	0.00	0.00
common myeloid progenitor CMP, donor1	12130-128D6	119.17	4.58	0.00	4.58
common myeloid progenitor CMP, donor2	12134-128E1	25.04	25.04	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	3.40	9.35	0.85	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	5.74	10.72	1.66	0.60
cord blood derived cell line:COBL-a untreated	10449-106F8	5.78	14.95	2.54	0.85
corpus callosum, adult, pool1	10042-101F6	60.26	2.21	0.44	0.44
cruciate ligament, donor2	10295-104G7	19.45	2.43	0.81	0.81
diaphragm, fetal, donor1	10069-101I6	13.64	1.61	0.80	0.00
diencephalon, adult	10193-103E4	31.68	1.44	0.48	0.48
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	5.97	10.79	0.23	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	83.60	8.98	1.28	0.51
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	52.48	2.17	1.44	0.72
ductus deferens, adult	10196-103E7	35.88	4.49	0.50	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	38.89	2.88	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	52.23	3.68	0.74	0.00
dura mater, adult, donor1	10041-101F5	42.20	4.54	0.83	0.17
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	16.21	3.11	0.44	0.67
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	21.92	2.01	0.43	0.57
embryonic pancreas cell line:1B2C6	10604-108F1	54.26	5.55	0.62	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	62.06	3.63	0.30	0.30
embryonic pancreas cell line:1C3IKEI	10606-108F3	59.28	5.25	0.62	0.00
embryonic pancreas cell line:2C6	10603-108E9	70.93	15.76	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	27.49	5.03	0.34	0.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	78.84	9.42	1.27	3.44
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	50.82	2.25	0.64	0.80
epidermoid carcinoma cell line:A431	10426-106D3	74.70	5.56	0.78	0.33
epidermoid carcinoma cell line:Ca Ski	10431-106D8	53.89	9.35	1.98	0.66
epididymis, adult	10197-103E8	38.93	3.14	0.84	0.00
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	107.33	5.14	0.35	1.06
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	27.13	3.54	0.39	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	58.19	5.64	1.05	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	56.89	6.30	0.59	0.69
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	55.79	3.81	0.78	0.45
esophagus, adult, pool1	10015-101C6	22.72	3.93	0.74	0.11
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	84.66	6.14	0.50	0.25
eye - muscle inferior rectus, donor1	10272-104E2	26.56	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	8.42	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	17.86	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	27.52	1.15	1.15	0.00
eye - vitreous humor, donor1	10268-104D7	23.32	2.91	1.46	0.00
eye, fetal, donor1	10054-101G9	37.88	2.80	0.76	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	38.98	4.10	0.51	0.26
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	15.91	2.14	0.71	0.24
frontal lobe, adult, pool1	10040-101F4	52.64	1.78	0.38	0.47
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	65.45	6.61	0.90	0.60
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	133.04	7.22	0.82	0.73
gall bladder, adult	10198-103E9	34.28	3.38	0.24	0.00
gamma delta positive T cells, donor1	11937-126A2	51.00	10.20	3.22	0.00
gamma delta positive T cells, donor2	11938-126A3	54.53	10.83	0.00	0.75
gastric adenocarcinoma cell line:MKN1	10614-108G2	85.33	7.60	0.84	1.06
gastric adenocarcinoma cell line:MKN45	10612-108F9	94.00	4.64	0.77	0.19
gastric cancer cell line:AZ521	10549-107H9	55.42	6.07	1.15	0.33
gastric cancer cell line:GSS	10560-108A2	40.27	2.75	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	55.06	1.37	1.60	1.14
giant cell carcinoma cell line:LU65	10487-107B1	17.21	1.26	0.11	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	48.85	8.96	0.56	0.14
glassy cell carcinoma cell line:HOKUG	10688-109F4	59.11	7.23	0.50	1.75
glioblastoma cell line:A172, tech_rep1	10444-106F3	109.35	18.79	3.80	2.74
glioblastoma cell line:A172, tech_rep2	10444-106F3	116.70	20.78	4.92	2.11
glioblastoma cell line:T98G	10485-107A8	36.31	11.37	1.32	0.44
glioma cell line:GI-1	10413-106B8	53.30	7.61	2.05	2.05
globus pallidus - adult, donor10196	10175-103C4	44.46	0.00	0.73	0.00
globus pallidus, adult, donor10252	10161-103A8	44.43	1.22	0.24	0.73
globus pallidus, adult, donor10258	10367-105F7	27.38	0.00	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	27.71	1.60	0.00	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	56.28	12.24	2.45	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	21.86	21.86	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	10.45	5.23	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	47.04	6.08	0.96	0.96
hIPS +CCl2, biol_rep1	14383-156B9	22.04	2.30	0.92	0.00
hIPS +CCl2, biol_rep2	14384-156C1	25.61	2.74	2.29	0.00
hIPS +CCl2, biol_rep3	14385-156C2	21.26	1.29	0.64	0.00
hIPS, biol_rep1	14380-156B6	33.06	0.00	1.44	0.00
hIPS, biol_rep2	14381-156B7	23.32	4.12	1.37	0.00
hIPS, biol_rep3	14382-156B8	41.93	0.00	0.00	1.10
hairy cell leukemia cell line:Mo	10712-109I1	14.37	8.33	0.29	0.29
heart - mitral valve, adult	10205-103F7	39.76	0.90	0.60	0.00
heart - pulmonic valve, adult	10206-103F8	26.93	1.05	0.78	0.00
heart - tricuspid valve, adult	10207-103F9	13.32	0.00	0.00	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	46.12	2.24	0.20	1.02
heart, adult, diseased, donor1	10051-101G6	25.98	2.13	0.00	0.43
heart, adult, pool1	10016-101C7	19.09	0.69	0.23	0.00
heart, fetal, pool1	10046-101G1	33.88	4.42	0.51	0.21
hepatic mesenchymal tumor cell line:LI90	10778-110G4	65.41	6.17	2.16	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	23.78	1.19	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	28.62	6.08	2.10	1.33
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	30.95	7.04	2.18	0.97
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	32.54	7.88	2.22	1.11
hepatoma cell line:Li-7	10484-107A7	27.03	4.34	0.22	0.33
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	19.60	6.63	0.90	0.80
hippocampus - adult, donor10196	10169-103B7	43.53	1.89	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	41.02	1.22	0.20	0.20
hippocampus, adult, donor10258	10374-105G5	57.26	1.49	1.00	0.50
hippocampus, newborn, donor10223	10363-105F3	26.08	1.41	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	29.30	3.66	1.83	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	38.29	4.12	0.39	0.59
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	27.93	3.55	0.51	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	53.00	0.56	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	45.70	2.07	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	37.96	3.04	0.38	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	45.54	1.46	0.29	0.29
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	48.47	2.59	0.00	0.43
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	47.55	2.50	0.00	0.83
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	31.97	2.60	0.47	0.71
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	42.11	2.25	0.00	0.64
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	45.78	0.67	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	26.45	5.16	0.78	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	30.95	3.44	0.49	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	27.06	6.98	1.75	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	58.99	2.86	0.19	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	58.43	3.92	0.44	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	37.48	2.00	0.50	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	34.48	2.26	0.38	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	48.20	3.18	0.00	0.45
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	41.66	2.51	0.63	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	48.17	1.80	0.16	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	42.68	2.03	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	54.11	1.49	0.30	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	30.48	4.99	0.37	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	30.24	3.99	0.00	0.57
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	38.38	5.31	2.04	0.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	41.90	2.46	0.35	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	56.06	1.58	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	49.93	2.42	0.61	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	52.75	2.59	1.03	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	67.74	1.99	0.00	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	39.25	1.80	0.26	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	40.65	2.30	0.26	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	62.09	3.79	0.76	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	46.04	3.02	0.67	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	34.54	3.62	0.24	0.48
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	25.85	5.79	0.89	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	37.56	3.41	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	40.95	3.36	0.31	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	22.77	9.76	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	31.77	3.31	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	50.90	1.09	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	43.06	1.45	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	32.74	1.07	0.00	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	38.19	1.19	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	37.51	2.71	0.27	0.27
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	35.83	1.08	0.00	0.00
immature langerhans cells, donor1	11904-125F5	8.72	5.81	0.00	0.24
immature langerhans cells, donor2	11905-125F6	26.93	4.75	0.00	1.58
insula, adult, pool1	10039-101F3	63.97	3.69	0.28	0.28
keratoacanthoma cell line:HKA-1	10791-110H8	54.30	25.36	4.55	1.63
kidney, adult, pool1	10017-101C8	38.95	5.11	0.60	0.50
kidney, fetal, pool1	10045-101F9	45.84	4.95	0.35	0.07
large cell lung carcinoma cell line:IA-LM	10509-107D5	117.03	5.54	1.42	0.71
large cell lung carcinoma cell line:NCI-H460	10839-111E2	34.28	12.17	1.24	0.83
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	60.55	7.52	1.28	0.00
left atrium, adult, donor1	10079-102A7	14.17	3.81	0.00	0.00
left ventricle, adult, donor1	10078-102A6	10.11	1.01	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	63.48	6.02	1.64	0.82
leiomyoma cell line:10964C	10569-108B2	120.35	12.93	6.47	0.72
leiomyoma cell line:15242A	10570-108B3	91.85	10.87	5.43	1.63
leiomyoma cell line:15425	10571-108B4	85.71	13.11	3.40	2.91
leiomyosarcoma cell line:Hs 5.T	10722-110A2	63.49	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	49.14	4.18	2.09	1.05
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	32.35	3.42	2.13	0.35
liposarcoma cell line:KMLS-1	10782-110G8	60.92	6.09	2.34	0.78
liposarcoma cell line:SW 872	10726-110A6	63.72	11.33	2.80	0.97
liver, adult, pool1	10018-101C9	40.68	4.54	0.49	0.97
liver, fetal, pool1	10086-102B5	35.75	0.94	0.94	0.00
locus coeruleus - adult, donor10196	10182-103D2	29.60	1.46	0.15	0.29
locus coeruleus, adult, donor10252	10165-103B3	35.62	1.11	0.37	0.18
locus coeruleus, adult, donor10258	10375-105G6	36.40	2.54	0.00	0.56
locus coeruleus, newborn, donor10223	10362-105F2	23.13	0.42	2.10	0.42
lung adenocarcinoma cell line:A549	10499-107C4	23.25	7.33	0.00	0.42
lung adenocarcinoma cell line:PC-14	10408-106B3	79.97	19.99	1.38	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	28.74	2.50	0.26	0.40
lung, adult, pool1	10019-101D1	27.17	7.21	0.24	0.24
lung, fetal, donor1	10068-101I5	55.65	2.00	1.43	0.29
lung, right lower lobe, adult, donor1	10075-102A3	33.91	3.21	0.92	0.46
lymph node, adult, donor1	10077-102A5	20.83	6.63	0.47	0.95
lymphangiectasia cell line:DS-1	10727-110A7	11.84	21.26	3.07	1.53
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	3.92	7.85	0.91	0.91
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	113.83	4.25	2.55	0.85
mature adipocyte, donor1	12231-129F8	43.07	0.89	0.44	0.00
mature adipocyte, donor2	12232-129F9	36.11	2.70	0.42	0.00
mature adipocyte, donor3	12233-129G1	31.06	1.90	0.24	0.00
mature adipocyte, donor4	12234-129G2	30.01	1.84	0.26	0.26
maxillary sinus tumor cell line:HSQ-89	10414-106B9	57.66	0.95	0.00	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	45.12	0.00	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	40.09	0.74	0.18	0.18
medial frontal gyrus, adult, donor10258	10368-105F8	37.49	0.64	0.32	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	32.41	0.85	0.00	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	46.24	1.69	0.34	0.34
medial temporal gyrus, adult, donor10252	10156-103A3	47.75	1.49	0.00	0.42
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	63.57	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	34.46	1.79	0.72	0.36
medulla oblongata - adult, donor10196	10174-103C3	22.07	3.24	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	39.94	1.86	0.00	0.15
medulla oblongata, adult, pool1	10038-101F2	44.73	1.96	0.49	0.49
medulla oblongata, newborn, donor10223	10361-105F1	29.51	2.08	0.00	0.69
medulloblastoma cell line:D283 Med	10838-111E1	58.45	4.21	0.22	0.22
medulloblastoma cell line:ONS-76	10759-110E3	56.37	2.20	1.10	0.12
melanoma cell line:COLO 679	10514-107E1	20.27	3.02	0.43	0.14
melanoma cell line:G-361	10465-106H6	71.39	3.26	1.09	0.81
meningioma cell line:HKBMM	10691-109F7	52.46	4.34	0.72	0.18
merkel cell carcinoma cell line:MKL-1	10843-111E6	29.96	2.64	1.76	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	63.51	1.56	0.52	0.52
mesenchymal precursor cell - adipose, donor1	11747-123G1	43.58	11.05	3.07	1.38
mesenchymal precursor cell - adipose, donor2	11748-123G2	44.54	6.18	1.64	1.09
mesenchymal precursor cell - adipose, donor3	11749-123G3	51.35	8.28	2.07	0.83
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	37.23	7.16	2.53	1.12
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	65.47	7.90	2.31	0.96
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	82.60	10.41	3.47	2.78
mesenchymal precursor cell - cardiac, donor1	11752-123G6	63.16	7.55	3.43	3.43
mesenchymal precursor cell - cardiac, donor2	11753-123G7	51.53	5.06	1.73	0.23
mesenchymal precursor cell - cardiac, donor3	11754-123G8	42.97	6.50	2.52	0.93
mesenchymal precursor cell - cardiac, donor4	11755-123G9	45.24	5.94	1.35	0.68
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	40.69	8.11	2.42	1.56
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	56.98	7.90	0.66	1.32
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	46.91	8.99	3.46	0.97
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	70.86	11.17	5.59	1.05
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	75.75	10.21	4.08	1.84
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	63.98	7.19	1.80	0.72
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	77.28	9.41	4.34	1.66
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	83.90	8.21	4.79	2.74
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	50.77	5.87	1.26	1.26
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	40.35	6.28	2.69	0.45
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	42.45	11.73	2.54	0.88
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	49.33	10.68	2.58	0.74
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	73.83	7.73	2.58	1.72
mesenchymal stem cell line:Hu5/E18	10568-108B1	37.47	8.00	0.84	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	69.41	7.76	1.83	0.91
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	64.20	9.21	3.58	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	72.51	6.54	2.62	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	66.55	9.55	1.23	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	58.60	8.71	1.41	0.47
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	67.35	8.12	3.72	2.03
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	64.84	7.07	3.93	1.57
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	57.00	6.95	0.93	0.93
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	144.91	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	78.74	11.54	4.90	1.73
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	64.25	7.36	2.45	1.78
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	71.38	5.53	5.29	1.68
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	69.67	7.33	3.67	1.47
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	61.76	9.73	3.02	1.01
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	70.41	7.78	3.28	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	58.42	9.02	2.15	1.29
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	82.03	8.20	0.00	2.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	61.98	5.16	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	68.53	7.79	0.97	1.30
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	84.39	7.27	7.27	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	79.43	5.86	2.67	2.67
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	59.70	5.72	4.09	2.45
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	66.08	5.05	1.17	1.55
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	94.44	6.30	6.30	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	80.47	7.95	2.98	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	52.44	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	67.01	7.12	2.37	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	75.54	8.53	0.00	2.44
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	189.37	0.00	27.05	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	69.67	8.23	3.17	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	77.95	3.79	1.38	1.72
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	70.92	15.04	2.15	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	71.85	3.99	3.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	61.99	10.33	3.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	70.90	5.70	2.04	1.63
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	58.79	5.56	3.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	63.67	1.18	0.59	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	69.20	6.86	0.31	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	72.18	2.67	0.00	4.01
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	40.21	2.37	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	41.09	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	52.32	0.69	0.69	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	46.51	2.97	0.49	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	44.86	1.12	1.12	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	51.52	2.54	0.64	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	50.37	2.01	0.00	0.40
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	45.79	2.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	64.62	3.80	2.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	48.55	1.82	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	63.27	9.04	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	45.30	2.47	0.82	0.82
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	45.44	1.59	0.60	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	43.81	1.30	0.97	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	51.95	2.04	1.02	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	92.07	7.74	0.77	0.77
mesothelioma cell line:ACC-MESO-1	10493-107B7	81.03	4.72	0.24	0.71
mesothelioma cell line:ACC-MESO-4	10494-107B8	75.29	4.17	0.46	0.93
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	68.38	17.09	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	44.80	11.82	2.47	0.62
mesothelioma cell line:Mero-25	10850-111F4	71.72	1.82	0.91	0.23
mesothelioma cell line:Mero-41	10851-111F5	41.81	3.42	0.49	0.00
mesothelioma cell line:Mero-48a	10852-111F6	46.72	5.31	1.11	0.89
mesothelioma cell line:Mero-82	10853-111F7	25.49	6.31	1.05	0.53
mesothelioma cell line:Mero-83	10854-111F8	40.34	5.28	1.70	0.00
mesothelioma cell line:Mero-84	10855-111F9	50.81	6.07	0.51	0.76
mesothelioma cell line:Mero-95	10856-111G1	37.47	6.21	1.86	0.83
mesothelioma cell line:NCI-H2052	10847-111F1	36.11	6.29	1.16	1.16
mesothelioma cell line:NCI-H226	10846-111E9	23.35	5.25	1.09	0.54
mesothelioma cell line:NCI-H2452	10848-111F2	74.99	8.37	1.54	1.37
mesothelioma cell line:NCI-H28	10845-111E8	36.13	4.07	0.00	0.51
mesothelioma cell line:No36	10857-111G2	31.97	1.63	0.33	0.00
mesothelioma cell line:ONE58	10858-111G3	36.31	8.40	0.54	0.54
migratory langerhans cells, donor1	11901-125F2	10.17	17.85	2.30	1.73
migratory langerhans cells, donor2	11902-125F3	11.11	13.19	0.85	0.98
migratory langerhans cells, donor3	11903-125F4	9.69	17.95	0.90	0.18
mixed mullerian tumor cell line:HTMMT	10689-109F5	65.62	3.92	0.98	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	66.34	3.39	1.06	0.64
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	25.57	3.92	0.92	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	11.80	10.28	1.14	0.95
myelodysplastic syndrome cell line:SKM-1	10772-110F7	55.99	5.36	0.37	0.37
myeloma cell line:PCM6	10474-106I6	37.95	31.82	3.36	2.57
myxofibrosarcoma cell line:MFH-ino	10600-108E6	26.38	5.07	0.51	1.01
myxofibrosarcoma cell line:NMFH-1	10684-109E9	27.46	4.12	0.78	0.59
nasal epithelial cells, donor1, tech_rep1	12226-129F3	36.44	1.00	0.33	0.11
nasal epithelial cells, donor1, tech_rep2	12226-129F3	34.34	0.88	0.15	0.07
nasal epithelial cells, donor2	12227-129F4	34.22	1.66	1.10	0.00
neuroblastoma cell line:CHP-134	10508-107D4	46.24	13.34	0.69	0.46
neuroblastoma cell line:NB-1	10539-107G8	41.53	5.80	1.87	2.25
neuroblastoma cell line:NBsusSR	10607-108F4	43.23	2.74	0.63	0.21
neuroblastoma cell line:NH-12	10555-107I6	59.63	9.88	0.93	0.75
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	37.96	11.62	0.95	2.61
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	46.25	5.23	0.48	0.48
neuroectodermal tumor cell line:TASK1	10774-110F9	24.15	2.01	0.60	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	58.49	6.36	1.91	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	37.80	6.65	1.33	0.53
neutrophil PMN, donor1	12133-128D9	44.62	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	0.00	13.28	0.00
neutrophil PMN, donor3	12141-128E8	9.47	9.47	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	29.77	8.79	1.01	1.52
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	19.21	3.20	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	65.40	5.45	0.64	0.64
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	54.39	11.82	1.05	0.79
nucleus accumbens, adult, pool1	10037-101F1	52.68	1.41	0.37	0.37
occipital cortex - adult, donor10196	10172-103C1	41.21	2.06	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	44.28	2.68	0.00	0.54
occipital cortex, newborn, donor10223	10355-105E4	39.31	1.82	0.36	0.73
occipital lobe, adult, donor1	10076-102A4	42.25	1.31	0.00	0.00
occipital lobe, fetal, donor1	10073-102A1	66.94	4.29	0.00	0.86
occipital pole, adult, pool1	10036-101E9	49.83	1.50	0.16	0.32
olfactory region, adult	10195-103E6	45.47	1.91	0.00	0.57
optic nerve, donor1	10277-104E7	52.03	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	129.74	3.19	1.37	1.14
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	54.13	7.01	0.96	0.14
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	46.39	3.05	0.68	0.34
oral squamous cell carcinoma cell line:SAS	10544-107H4	24.14	9.36	0.12	0.35
osteoclastoma cell line:Hs 706.T	10704-109H2	80.25	8.82	3.23	1.18
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	38.31	4.67	0.93	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	38.38	5.73	1.27	0.42
ovary, adult, pool1	10020-101D2	33.63	2.97	0.35	0.09
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	34.10	4.03	1.47	0.37
pancreas, adult, donor1	10049-101G4	30.10	7.53	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	72.12	5.03	0.56	1.40
papillary adenocarcinoma cell line:8505C	10437-106E5	99.15	9.71	2.38	0.68
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	42.89	27.16	1.82	0.83
paracentral gyrus, adult, pool1	10035-101E8	46.95	1.65	0.27	0.64
parietal cortex, adult, donor10258	10373-105G4	34.50	0.73	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	41.38	0.94	0.00	0.94
parietal lobe, adult, donor10252	10157-103A4	39.05	1.14	0.00	0.57
parietal lobe, adult, pool1	10034-101E7	51.46	2.03	0.26	0.18
parietal lobe, fetal, donor1	10072-101I9	69.83	6.79	0.97	1.94
parietal lobe, newborn, donor10223	10356-105E5	26.92	0.75	0.37	0.75
parotid gland, adult	10199-103F1	25.90	5.55	1.23	0.62
penis, adult	10200-103F2	23.10	6.45	0.00	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	36.82	3.16	0.74	0.37
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	69.21	6.70	1.17	0.73
pineal gland - adult, donor10196	10179-103C8	41.28	0.00	0.65	1.29
pineal gland, adult, donor10252	10160-103A7	39.68	4.15	0.00	0.00
pineal gland, adult, donor10258	10377-105G8	29.47	1.88	0.63	0.00
pituitary gland - adult, donor10196	10180-103C9	69.81	4.05	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	68.80	4.17	0.52	1.56
pituitary gland, adult, donor10258	10378-105G9	56.18	8.51	3.40	0.00
placenta, adult, pool1	10021-101D3	43.32	7.53	1.40	0.22
plasma cell leukemia cell line:ARH-77	10840-111E3	11.92	12.85	1.46	0.40
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	47.63	8.56	0.78	1.25
pons, adult, pool1	10033-101E6	35.20	1.12	0.17	0.26
postcentral gyrus, adult, pool1	10032-101E5	53.87	1.74	0.44	0.61
promyelocytes/myelocytes PMC, donor1	12132-128D8	27.19	2.09	2.09	2.09
promyelocytes/myelocytes PMC, donor2	12136-128E3	22.03	11.02	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	11.74	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	50.98	5.54	1.02	0.00
prostate cancer cell line:PC-3	10439-106E7	33.58	5.08	0.91	0.54
prostate, adult, pool1	10022-101D4	29.47	2.90	0.73	0.27
putamen, adult, donor10196	10176-103C5	55.00	0.71	0.00	0.00
putamen, adult, donor10252	10152-102I8	39.21	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	37.16	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	34.79	0.48	0.24	0.00
putamen, newborn, donor10223	10365-105F5	17.24	0.75	0.75	0.00
rectal cancer cell line:TT1TKB	10469-106I1	28.51	8.44	0.58	0.87
rectum, fetal, donor1	10067-101I4	55.64	5.56	1.39	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	64.87	7.00	1.27	0.42
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	63.37	14.50	1.66	0.41
retina, adult, pool1	10030-101E3	48.21	3.48	0.20	0.20
retinoblastoma cell line:Y79	10475-106I7	32.99	7.53	0.78	0.52
rhabdomyosarcoma cell line:KYM-1	10787-110H4	45.00	4.18	1.60	0.61
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	22.78	3.09	0.00	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	47.74	9.09	3.03	0.00
salivary acinar cells, donor1	11771-123I7	27.19	5.83	0.81	0.32
salivary acinar cells, donor2	11772-123I8	26.71	6.88	1.24	0.28
salivary acinar cells, donor3	11773-123I9	33.10	7.94	0.66	0.00
salivary gland, adult, pool1	10093-102C3	61.20	12.01	0.57	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	31.20	5.48	1.01	0.34
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	29.51	7.29	0.71	0.24
seminal vesicle, adult	10201-103F3	42.33	2.65	0.00	0.53
serous adenocarcinoma cell line:JHOS-2	10639-108I9	59.27	8.50	0.73	0.97
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	35.98	4.78	1.01	0.75
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	46.16	6.02	1.00	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	66.89	14.78	2.01	1.07
signet ring carcinoma cell line:Kato III	10436-106E4	51.95	6.30	0.66	0.00
signet ring carcinoma cell line:NUGC-4	10483-107A6	28.51	9.03	0.65	0.39
skeletal muscle - soleus muscle, donor1	10282-104F3	15.61	0.00	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	20.87	0.48	0.00	0.00
skeletal muscle, fetal, donor1	10066-101I3	26.13	3.02	0.00	0.00
skin, adult, donor1	10074-102A2	61.07	13.57	0.00	0.00
skin, fetal, donor1	10065-101I2	38.50	4.42	0.63	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	44.36	5.67	1.33	0.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	49.49	2.84	0.63	0.63
small cell lung carcinoma cell line:DMS 144	10841-111E4	57.44	4.63	0.39	0.39
small cell lung carcinoma cell line:LK-2	10541-107H1	46.48	4.62	0.82	0.16
small cell lung carcinoma cell line:NCI-H82	10842-111E5	20.27	2.25	0.16	0.48
small cell lung carcinoma cell line:WA-hT	10562-108A4	50.77	9.37	1.53	1.74
small intestine, adult, pool1	10024-101D6	21.38	10.39	1.55	0.48
small intestine, fetal, donor1	10064-101I1	25.06	5.90	0.25	0.49
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	64.63	7.18	1.03	0.51
smooth muscle, adult, pool1	10048-101G3	28.17	0.78	0.52	0.26
somatostatinoma cell line:QGP-1	10781-110G7	26.27	4.02	1.07	1.07
spinal cord - adult, donor10196	10181-103D1	26.38	2.06	0.23	0.00
spinal cord, adult, donor10252	10159-103A6	34.70	5.13	0.00	0.00
spinal cord, adult, donor10258	10369-105F9	33.90	2.08	0.00	0.69
spinal cord, fetal, donor1	10056-101H2	57.93	1.22	0.00	0.00
spinal cord, newborn, donor10223	10359-105E8	28.93	3.21	0.00	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	45.70	7.32	2.69	0.60
spleen, adult, pool1	10025-101D7	19.05	10.46	1.21	0.11
spleen, fetal, pool1	10044-101F8	26.14	9.69	0.87	0.24
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	4.14	11.80	1.04	0.72
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	130.44	15.38	1.52	0.19
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	80.72	3.84	0.70	1.40
squamous cell carcinoma cell line:T3M-5	10616-108G4	46.91	5.86	1.17	0.39
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	74.40	4.73	0.56	0.23
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	20.76	0.00	0.42	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	30.88	6.77	0.85	1.27
stomach, fetal, donor1	10062-101H8	35.24	2.14	0.00	0.00
submaxillary gland, adult	10202-103F4	41.02	9.11	1.14	0.57
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	39.88	1.25	0.21	0.21
substantia nigra, adult, donor10258	10371-105G2	41.90	1.55	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	23.32	0.00	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	27.97	4.13	0.46	0.92
temporal lobe, adult, pool1	10031-101E4	63.58	2.88	0.17	0.51
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	55.56	4.27	0.71	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	71.21	3.08	2.20	0.88
tenocyte, donor1	11763-123H8	90.77	10.47	1.05	2.09
tenocyte, donor2	11765-123I1	57.23	5.34	2.67	0.38
tenocyte, donor3	11768-123I4	76.36	4.82	1.48	0.74
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	26.68	3.57	0.34	0.17
teratocarcinoma cell line:NCR-G1	10798-110I6	29.13	6.94	1.08	0.77
teratocarcinoma cell line:PA-1	10807-111A6	24.95	3.87	0.46	0.00
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	38.59	1.65	1.27	0.38
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	68.07	1.89	0.00	0.38
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	29.01	1.96	0.11	0.11
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	56.35	3.58	0.00	0.33
testis, adult, pool1	10026-101D8	43.49	3.54	0.64	1.07
testis, adult, pool2	10096-102C6	86.16	3.16	1.35	0.90
thalamus - adult, donor10196	10168-103B6	29.81	1.10	0.00	0.00
thalamus, adult, donor10252	10154-103A1	43.13	1.56	0.00	0.31
thalamus, adult, donor10258, tech_rep1	10370-105G1	35.41	1.54	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	20.75	1.15	0.16	0.16
thalamus, newborn, donor10223	10366-105F6	23.59	1.73	0.00	0.00
throat, adult	10209-103G2	24.97	3.25	1.00	0.25
throat, fetal, donor1	10061-101H7	39.92	3.66	0.61	0.30
thymic carcinoma cell line:Ty-82	10803-111A2	74.72	8.35	1.59	0.60
thymus, adult, pool1	10027-101D9	29.03	7.75	0.99	1.79
thymus, fetal, pool1	10043-101F7	30.65	7.27	1.45	1.45
thyroid carcinoma cell line:KHM-5M	10776-110G2	23.80	8.11	1.06	0.66
thyroid carcinoma cell line:TCO-1	10783-110G9	64.26	9.92	2.10	1.12
thyroid, adult, pool1	10028-101E1	44.88	5.23	0.56	0.19
thyroid, fetal, donor1	10060-101H6	42.98	2.37	0.26	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	30.80	3.08	0.00	0.00
tongue, adult	10203-103F5	19.30	1.40	0.23	0.00
tongue, fetal, donor1	10059-101H5	21.68	2.36	0.39	0.39
tonsil, adult, pool1	10047-101G2	30.35	11.72	1.30	0.30
trachea, adult, pool1	10029-101E2	28.96	4.09	0.74	0.00
trachea, fetal, donor1	10058-101H4	40.78	5.39	0.38	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	49.95	5.67	2.13	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	46.10	4.86	0.81	0.61
transitional-cell carcinoma cell line:JMSU1	10492-107B6	82.73	4.23	0.47	0.00
tridermal teratoma cell line:HGRT	10694-109G1	51.37	3.81	1.90	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	31.74	8.47	1.19	0.51
umbilical cord, fetal, donor1	10057-101H3	54.25	4.17	4.17	2.09
uterus, adult, pool1	10100-102D1	48.46	4.78	0.68	0.00
uterus, fetal, donor1	10055-101H1	50.17	6.14	0.00	0.00
vagina, adult	10204-103F6	8.40	3.23	0.00	0.00
vein, adult	10191-103E2	22.58	7.01	0.22	0.22
xeroderma pigentosum b cell line:XPL 17	10563-108A5	4.54	12.55	0.80	0.53